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B. Introduction 
 
B.1. Chlamydiae 
 
B.1.1. The order Chlamydiales 
Chlamydiae are a group of obligate intracellular bacteria that constitute the single order 
Chlamydiales in the phylum Chlamydiae. A hallmark of all chlamydiae is their unique 
biphasic developmental cycle (Ward 1988; Moulder 1991; Abdelrahman et al. 2005). Until 
the identification of Chlamydia-like endosymbionts in acanthamoebae in the 1990s (Fritsche 
et al. 1993; Amann et al. 1997; Birtles et al. 1997; Fritsche et al. 2000; Horn et al. 2000), the 
only known family in the order Chlamydiales were the Chlamydiaceae, a family exclusively 
comprised of clinically relevant human and animal pathogens. Since then, numerous 
representatives of new chlamydial families were discovered and a total of seven new families 
of so-called environmental chlamydiae has been described (Kuo et al. 2008). 
 
B.1.2. Clinical chlamydiae 
Members of the family Chlamydiaceae are often referred to as clinical chlamydiae, since all 
species exhibit pathogenic potential in humans or animals. The family consists of two genera, 
Chlamydia and Chlamydophila (Everett et al. 1999). Species of the genus Chlamydia seem to 
be restricted to mammals as host organisms, while species of the genus Chlamydophila do not 
exhibit such a strict host specificity as they were also shown to infect amphibians, reptiles and 
birds, as well as mammalian species (Corsaro et al. 2004). The family Chlamydiaceae 
includes two of the most widespread human pathogens, Chlamydia trachomatis and 
Chlamydophila pneumoniae. C. trachomatis is the most common cause of bacterial sexually 
transmitted infections, with over 90 million new cases per year (WHO 2001). It is also the 
causative agent of trachoma that affects the inner upper eyelid and cornea and is one of the 
leading infectious causes of blindness (WHO 2009). C. pneumoniae is a widely distributed 
respiratory pathogen that accounts for an estimated 2 to 43% of community-acquired 
pneumonia and 5% of bronchitis and sinusitis cases (Kuo et al. 1995; Wellinghausen et al. 
2006). Furthermore, it is possibly associated with several chronic diseases of unknown cause, 
such as atherosclerosis, multiple sclerosis, asthma and Alzheimer’s disease (Mahony et al. 
2003). Another major concern for public health is the zoonotic potential of Chlamydophila 
psittaci and Chlamydophila abortus. C. psittaci is the cause of avian psittacosis in birds, but 
infection can also be transferred to humans, where it leads to psittacosis with severe clinical 
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symptoms (Elder et al. 1999; Gaede et al. 2008). C. abortus, the causative agent of enzootic 
abortions in sheep (Aitken 2000; Longbottom et al. 2003), can also be transferred to humans, 
posing a threat especially to pregnant women  (Longbottom et al. 2003).  
 
B.1.3. Environmental chlamydiae 
The term ‘environmental chlamydiae’ (Horn et al. 2001) describes the novel Chlamydia-like 
bacteria that were identified in the last years that do not belong to the family Chlamydiaceae. 
Their discovery has shown that the phylogenetic diversity is substantially greater than 
expected and has lead to the description of seven additional families in the order 
Chlamydiales: Parachlamydiaceae, Simkaniaceae (Everett et al. 1999), Waddliaceae 
(Rurangirwa et al. 1999), Piscichlamydiaceae (Draghi et al. 2004), Rhabdochlamydiaceae 
(Kostanjsek et al. 2004; Corsaro et al. 2007), Criblamydiaceae (Thomas et al. 2006), and 
Clavochlamydiaceae (Karlsen et al. 2008) (Figure 1). However, the actual diversity is 
expected to be even larger, indicated by the detection of phylogenetically diverse rRNA 
sequences related to recognized chlamydiae in a great number of different habitats 
(Ossewaarde et al. 1999; Corsaro et al. 2001; Horn et al. 2001; Corsaro et al. 2002; Horn 
2008). 
 
 
Figure 1. Phylogenetic 16S rRNA tree showing the diversity in the order Chlamydiales. 
The eight families described so far are indicated in different colours. From Horn 2008. 
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The majority of environmental chlamydiae identified so far belong to the Parachlamydiaceae 
and they were found mainly as symbionts of free-living amoebae (Fritsche et al. 1993; Amann 
et al. 1997; Birtles et al. 1997; Fritsche et al. 2000; Horn et al. 2000). Members of the other 
families, however, exhibit a host spectrum of remarkable phylogenetic diversity, with host 
organisms ranging from vertebrates including mammals, amphibians, birds, reptiles, and fish 
over insects to crustaceans (Horn 2008). The clinical relevance of environmental chlamydiae 
is still being discussed. There are some indications that environmental chlamydiae might be 
involved in human diseases (Lieberman et al. 1997; Marrie et al. 2001; Greub et al. 2002; 
Friedman et al. 2003; Corsaro et al. 2006; Baud et al. 2007; Haider et al. 2008), but proof of a 
causal relationship between environmental chlamydiae and human disease is still missing. 
 
 
B.2. Free-living amoebae as hosts for bacterial endosymbionts 
 
Free-living amoebae are ubiquitous protozoa that play an important ecological role in 
regulating microbial populations as major predators of bacteria, fungi, algae, and other 
protozoa (Rodriguez-Zaragoza 1994). Microorganisms are internalized by phagocytosis 
generally followed by digestion in phagolysosomes. Some bacteria, however, have evolved 
strategies to survive internalization and proliferate within free-living amoebae (Proca-Ciobanu 
et al. 1975; Fritsche et al. 1998; Greub et al. 2004). These amoeba-resistant bacteria either use 
free-living amoebae transiently as alternate hosts or are able to maintain an evolutionary 
stable association as endosymbionts (Birtles et al. 1996; Amann et al. 1997; Greub et al. 
2004). Previously identified evolutionary lineages of bacterial endosymbionts of free-living 
amoebae are affiliated with the Alphaproteobacteria, Betaproteobacteria, Bacteroidetes, and 
Chlamydiae, a distribution that strongly suggests that symbiosis between bacteria and 
amoebae was developed several times independently during evolution (Horn et al. 2004). In 
case of a transient relationship the bacteria merely exploit the amoebae as a vessel for 
replication and dispersal. Many important human pathogens have been reported to deploy this 
strategy, the best studied example being Legionella pneumophila, where interaction with 
amoebae is considered to be central to its pathogenesis and ecology and a prerequisite for the 
infection of humans (reviewed in Molmeret et al. 2005). It has been suggested that interaction 
with free-living amoebae helps intracellular pathogens to develop and evolve mechanisms for 
a pathogenic lifestyle in higher eukaryotes, giving birth to the ‘protozoan gym’ hypothesis 
according to which free-living amoebae act as training grounds for intracellular bacterial 
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pathogens (Harb et al. 2000; Molmeret et al. 2005). Additionally, the ability to survive 
intracellularly in amoebae offers protection from harsh environmental conditions, making 
free-living amoebae clinically relevant as reservoirs and vectors of bacterial pathogens. For 
this reason, they are also referred to as ‘Trojan Horses of the microbial world’ (Barker et al. 
1994). 
 
 
B.3. Protochlamydia amoebophila 
 
Protochlamydia amoebophila UWE25 is an environmental chlamydia recovered as an 
endosymbiont of an Acanthamoeba sp. isolated from a soil sample from western Washington 
State, USA (Fritsche et al. 1993; Fritsche et al. 2000). It belongs to the family 
Parachlamydiaceae and was proposed to constitute a new genus, since the 16S rRNA and 
23S rRNA genes showed sequence identities of only 92.9% and 90.3%, respectively, to its 
closest relative within the Parachlamydiaceae (Collingro et al. 2005). The complete genome 
sequence of P. amoebophila UWE25 is available and it is the first and so far the only 
completely sequenced genome of a member of the environmental chlamydiae (Horn et al. 
2004). Its genome is about twice as large as the genomes of any of the pathogenic chlamydia 
species investigated to date (Stephens et al. 1998; Kalman et al. 1999; Read et al. 2000; Shirai 
et al. 2000; Read et al. 2003; Carlson et al. 2005; Thomson et al. 2005; Azuma et al. 2006; 
Thomson et al. 2008), indicating a less advanced reduction of genomic content (Horn et al. 
2004). In contrast to the Chlamydiaceae, P. amoebophila has retained several key features of 
the last common chlamydial ancestor, like a complete tricarboxylic acid cycle, but it still 
possesses major virulence mechanisms of present-day pathogenic chlamydiae, including a 
type three secretion system (Horn et al. 2004). Using the genome sequence, it was possible to 
design a microarray chip with oligonucleotide probes covering all open reading frames 
(ORFs) of the P. amoebophila genome, with the aim of studying the expression of temporally 
regulated genes during the chlamydial developmental cycle (Haider, unpublished). 
 
 
B.4. The chlamydial developmental cycle 
 
Chlamydiae are characterized by a unique biphasic developmental cycle that includes 
morphologically and physiologically distinct forms, the elementary body (EB) and the 
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reticulate body (RB) (Ward 1988; Hatch 1999; Abdelrahman et al. 2005). The EB is the 
infectious stage. It is metabolically inactive and adapted for survival in extracellular 
environments by an osmotically stable cell envelope (Hatch 1996) while the RB represents the 
reproductive, intracellular stage that is metabolically active but non-infectious. At the 
beginning of an infection cycle an EB attaches to the host cell and is taken up by a process 
originally termed ‘parasite-specified endocytosis’ (Byrne et al. 1978). However, in vitro 
studies could show that chlamydiae employ a variety of different attachment and entry 
mechanisms (Soderlund et al. 1983; Ward et al. 1984; Hodinka et al. 1986; Hodinka et al. 
1988; Prain et al. 1989; Wyrick et al. 1989; Schramm et al. 1995; Escalante-Ochoa et al. 
2000), and it is quite likely that they have evolved several, possibly redundant mechanisms of 
entry to guarantee their uptake (Scidmore 2006). Once internalized (Figure 2, step A), the 
chlamydiae remain inside a host-derived membrane vesicle termed chlamydial inclusion 
(Hackstadt et al. 1997), where the differentiation from EB to RB and subsequent replication 
take place (Figure 2, step B). Following this period of rapid cell division, RBs re-differentiate 
to EBs (Figure 2, step C) and leave the host cell either by a process called extrusion (Figure 2, 
step D) or via lysis (Figure 2, step E) (Hybiske et al. 2007). 
 
 
Figure 2. The developmental cycle of chlamydiae in free-living amoebae. Extracellular 
elementary bodies (EBs, shown in blue) are internalized (A) and differentiate to reticulate 
bodies (RBs, shown in red), which start multiplying and form large or single-cell inclusions 
(B). At some point, RBs re-differentiate to EBs (C) and are released within vesicles (D) or by 
lysis of the amoebae (E) to complete the infection cycle. Modified from Horn 2008. 
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Since the developmental stages are morphologically distinct (Ward 1988), the developmental 
cycle of several clinical but also environmental chlamydiae could be thoroughly described by 
electron microscopy (Matsumoto 1988; Ward 1988; Miyashita et al. 1993; Kahane et al. 
2001; Greub et al. 2002; Kahane et al. 2002). The regulatory mechanisms that trigger these 
morphological changes are of great interest and need to be investigated on the molecular 
level. Chlamydiae are genetically inaccessible and molecular investigations are additionally 
complicated by their obligate intracellular growth, therefore whole genome DNA microarrays 
are a valuable tool to study the complex interactions between chlamydiae and their host cells 
during the developmental cycle. 
 
 
B.5. DNA microarrays 
 
DNA microarrays consist of a serial array of microscopic spots of DNA oligonucleotides that 
are displayed on the solid surface of a glass slide (reviewed in Watson et al. 1998; Duggan et 
al. 1999; Graves 1999). The DNA spots, commonly representing single genes, are 
immobilized on the slide by covalent attachment to a chemical matrix. One chip can contain 
spots of DNA segments corresponding to all the genes of an organism, thus permitting global 
analysis of transcription by hybridization with samples of fluorescently labeled cDNA. The 
immobilized oligonucleotides are called probes and the labeled samples are referred to as 
targets (Phimister 1999). In the last years, microarrays have become an important tool in 
microbiology (Dharmadi et al. 2004), especially due to a combination of features, namely 
high throughput, parallelism, miniaturization, speed, and automation (Gupta et al. 1999). 
 
DNA microarrays have already been used to study the global expression of temporally 
regulated genes during the chlamydial developmental cycle (Shaw et al. 2000; Mahony 2002; 
Belland et al. 2003; Nicholson et al. 2003; Mäurer et al. 2007). According to their temporal 
expression pattern the genes of C. trachomatis and C. pneumoniae were assigned to three 
major clusters, the early-, the mid- and the late-cycle genes (Shaw et al. 2000; Mahony 2002). 
Early-cycle genes function to initiate the synthesis of macromolecules and to establish the 
intracellular niche, mid-cycle genes are coding for enzymes of intermediary metabolism and 
structural proteins and late-cycle genes are involved in the terminal differentiation of RBs 
back to EBs (Shaw et al. 2000; Mahony 2002). Another class of so-called tardy genes has 
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been suggested to account for genes that are mainly coding for mRNA that is carried over to 
EBs (Mäurer et al. 2007). 
 
 
B.6. The P. amoebophila whole genome microarray 
 
The P. amoebophila whole genome microarray (Haider, unpublished) consists of 2,031 
oligonucleotide probes corresponding to all putative ORFs. The program OligoWiz 2.0 
(Nielsen et al. 2003) was used to design the 50-mer (±5 bases) oligonucleotides. A 20 dATP 
spacer (A-spacer) was added to the 5’-end of each oligonucleotide in order to increase the on-
chip accessibility of spotted probes to target DNA (Shchepinov et al. 1997; Southern et al. 
1999). The oligonucleotides were synthesized by Microsynth (Microsynth GmbH, Balgach, 
Switzerland) in 384-well microtiter plates with a C6-amino linker modification at the 5’-end 
and provided in concentrations of 100 µM in 50% dimethyl sulfoxide (DMSO) to prevent 
evaporation during storage (Hegde et al. 2000). Oligonucleotides as well as several negative 
and positive controls are arrayed in triplicates, resulting in a total of 6132 spots per 
microarray chip. Using this microarray, it was possible to verify the transcription of 61% of 
the genes in the P. amoebophila genome during infection and thus obtain first insights into its 
gene expression profile (Haider, unpublished). 
 
 
B.7. Aims of the diploma thesis 
 
The objective of my diploma thesis was the optimization of the whole-genome microarray 
described above and the establishment of a procedure suitable for studying the gene 
expression of P. amoebophila. P. amoebophila is an obligate intracellular Chlamydia-like 
bacterium infecting amoebal cells and, like pathogenic chlamydiae, possesses a unique 
biphasic life cycle. The whole genome microarray should provide new insights about genes 
important for the differentiation stages and lead to a broader understanding of the chlamydial 
developmental cycle. When I started my diploma thesis, the design of the microarray and the 
evaluation of the hybridization were already completed and preliminary results had been 
obtained about the global gene expression profile of P. amoebophila during asynchronous 
infection (Haider, unpublished). The microarray procedure that was used to obtain these 
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results, however, was not performing well at that time and more efforts for optimization of the 
method were necessary. 
 
The hitherto undiscovered diversity of chlamydiae in the environment is expected to be huge 
(Ossewaarde et al. 1999; Corsaro et al. 2001; Horn et al. 2001; Corsaro et al. 2002; Horn 
2008). Therefore, another aim of my diploma thesis was the isolation of free-living amoebae 
from environmental samples in order to look for previously unknown symbioses between 
free-living amoebae and environmental chlamydiae or other bacterial endosymbionts. 
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C. Materials and Methods 
 
C.1. Software 
 
Table 1. Software used 
Software Company 
 Argus X1 V.4  biostep GmbH, Jahnsdorf, Germany 
 AxioVision 4  Carl Zeiss MicroImaging GmbH, Jena, Germany 
 FinchTV V.1.4.0  Geospiza Inc., Seattle, WA, USA 
 GenePix Pro 5.1  Molecular Devices GmbH, Ismaning/München, Germany 
 Microsoft Office 2003  Microsoft Corporation, Redmond, WA, USA 
 
 
C.2. Technical equipment 
 
Table 2. Technical equipment used 
Equipment Company 
 5804 R centrifuge  Eppendorf AG, Hamburg, Germany 
 ABI 3130x Genetic Analyzer  Applied Biosystems, Austin, TX, USA 
 Analytical Plus AP110 analytical balance  Ohaus Corporation, Pine Brooks, NJ, USA 
 BioView UV transillumator  biostep GmbH, Jahnsdorf, Germany 
 BL3100 balance  Sartorius AG, Göttingen, Germany 
 CCD camera AxioCam HRc  Carl Zeiss MicroImaging GmbH, Jena, Germany 
 Confocal laser scanning microscope LSM 510 Meta  Carl Zeiss MicroImaging GmbH, Jena, Germany 
 Epifluorescence microscope Axioplan 2 imaging  Carl Zeiss MicroImaging GmbH, Jena, Germany 
 FastPrep FP120 homogenizer  Bio 101/Savant, Farmingdale, NY, USA 
 GenePix 4100 microarray scanner  Molecular Devices GmbH, Ismaning/München, Germany 
 GFL type 1004 water bath  GFL - Ges. f. Labortechnik mbH, Burgwedel, Germany 
 iCycler thermal cycler  Bio-Rad Laboratories, Hercules, CA, USA 
 IKAMAG RCT basic magnetic stirrer  IKA Werke GmbH & Co.KG, Staufen, Germany 
 Incubator  Binder GmbH, Tuttlingen, Germany 
 inoLab pH Level 1 pH meter  WTW GmbH & Co.KG, Weilheim, Germany 
 Inverse microscope Axiovert 25  Carl Zeiss MicroImaging GmbH, Jena, Germany 
 Laminar flow hood Holten LaminAir model 1.2  Holten, Jouan Nordic, Allerød, Denmark 
 Laminar flow hood Holten LaminAir model 1.8  Holten, Jouan Nordic, Allerød, Denmark 
 Mastercycler gradient thermal cycler  Eppendorf AG, Hamburg, Germany 
 MicroGrid 610/TAS microarray spotter  BioRobotics Ltd, Cambridge, UK 
 Mikro 22R centrifuge  Hettich AG, Bäch, Switzerland 
 Milli-Q Biocel water purification system  Millipore GmbH, Vienna, Austria 
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 Mixing Block MB-102  Biozym Scientific GmbH, Hessisch Oldendorf, Germany 
 NanoDrop ND-1000 spectrophotometer   PEQLAB Biotechnologie GmbH, Erlangen, Germany 
 Neubauer counting chamber  Marienfeld GmbH & Co.KG, Lauda-Königshofen, Germany 
 OptimaTM L-100 XP ultracentrifuge  Beckman Coulter, Inc., Palo Alto, CA, USA 
 PowerPac Basic power supply  Bio-Rad Laboratories, Hercules, CA, USA 
 Ribonucleic acid, type VI from Torula Yeast  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Rotina 35R centrifuge  Hettich AG, Bäch, Switzerland 
 SD 220 VAC micro centrifuge  Carl Roth GmbH & Co.KG, Karlsruhe, Germany 
 SONOPLUS HD2070 sonicator  BANDELIN electronic GmbH & Co. KG, Berlin, Germany 
 Sub-Cell GT agarose gel electrophoresis system  Bio-Rad Laboratories, Hercules, CA, USA 
 SW41 Ti ultracentrifuge rotor  Beckman Coulter, Inc., Palo Alto, CA, USA 
 Thermo Haake DC10 water bath  Thermo Haake GmbH, Burgwedel, Germany 
 ThermoTWISTER comfort  Quantifoil Instruments GmbH, Jena, Germany 
 Vacufuge Concentrator 5301  Eppendorf AG, Hamburg, Germany 
 Varioclav 135 S H+P steam sterilizer  H+P Labortechnik GmbH, Oberschleißheim, Germany 
 Varioclav 25 T H+P table top steam sterilizer  H+P Labortechnik GmbH, Oberschleißheim, Germany 
 Vortex-Genie 2  Scientific Industries, Inc., Bohemia, NY, USA 
 VWR Ultrasonic Cleaner USC100T  VWR International bvba/sprl, Leuven, Belgium 
 
 
C.3. Kits and expendable items 
 
Table 3. Kits used 
Kit Company 
 DecaLabel DNA Labeling Kit  Fermentas GmbH, St.Leon-Rot, Germany 
 DNeasy Blood and Tissue Kit  QIAGEN, Valencia, CA, USA 
 illustra GenomiPhi V2 DNA Amplification Kit  GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
 MICROBEnrich Kit  Applied Biosystems/Ambion, Austin, TX, USA 
 RNEasy Mini Kit  QIAGEN, Valencia, CA, USA 
 QIAquick Nucleotide Removal Kit  QIAGEN, Valencia, CA, USA 
 QIAquick PCR Purification Kit  QIAGEN, Valencia, CA, USA 
 
Table 4. Expendable items used 
Expendable item Company 
 Bead beater tubes (2 mL)  Bio 101/Savant, Farmingdale, NY, USA 
 Culture flasks 10 mL (25 cm²), sterile  Iwaki Europe GmbH, Willich, Germany 
 Culture flasks 150 mL (500 cm²), sterile  Iwaki Europe GmbH, Willich, Germany 
 Glass beads (0.75-1.0 mm)  Carl Roth GmbH & Co.KG, Karlsruhe, Germany 
 Greiner tubes (15 mL, 50 mL), sterile  Greiner Bio-One GmbH, Frickenhausen, Germany 
 HybriWell FL Sealing Systems  Grace Bio-Labs, Bend, OR, USA 
  C. Materials and Methods 
 17 
 Microarray slides VSS-25C, silylated, clear  CEL Associates, Los Angeles, CA, USA 
 Microcentrifuge tubes (1.5 mL)  GenXpress Service & Vertrieb GmbH, Wr. Neudorf, Austria 
 Microcentrifuge tubes (2 mL)  Greiner Bio-One GmbH, Frickenhausen, Germany 
 Microscopic slides, black epoxy resin colour mask, 
 10 reaction wells, Ø 6 mm 
 Marienfeld GmbH & Co.KG, Lauda-Königshofen, Germany 
 MicroSpot 2500 split pins   Zinsser Analytic GmbH, Frankfurt, Germany 
 Omnifix 5 mL syringe, single use, sterile  B. Braun Melsungen AG, Melsungen, Germany 
 Omnifix 50 mL syringe, single use, sterile  B. Braun Melsungen AG, Melsungen, Germany 
 PCR tubes (0.2 mL)  Biozym Scientific GmbH, Hessisch Oldendorf, Germany 
 Petri Dishes, 90 mm, triple vents, sterile  Sterilin Ltd, Aberbargoed, UK 
 Pipette tips, various sizes  Carl Roth GmbH & Co.KG, Karlsruhe, Germany 
 Plastic pipettes (10 mL), single use, sterile  Sterilin Ltd, Aberbargoed, UK 
 Sterican Needles (Ø 0.45 x 25 mm), sterile  B. Braun Melsungen AG, Melsungen, Germany 
 Syringe filter, single use, sterile, 0.20 µm pore size  Asahi Techno Glass Corporation, Funabashi-City, Japan 
 Syringe filter, single use, sterile, 1.20 µm pore size  Sartorius AG, Göttingen, Germany 
 Ultracentrifuge tubes  Beckham Coulter, Inc., Palo Alto, CA, USA 
 
 
C.4. Chemicals and enzymes 
 
Table 5. Chemicals used 
Chemicals Company 
 Agar  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Ammonium acetate (CH3COONH4)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Bacto Peptone  Becton, Dickinson and Company, Sparks, MD, USA 
 Biozym LE Agarose  Biozym Scientific GmbH, Hessisch Oldendorf, Germany 
 Blocking reagent  Roche Diagnostics GmbH, Mannheim, Germany 
 Bovine serum albumine (BSA)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Boric acid  (H3BO3)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Calcium chloride dihydrate (CaCl2*2H2O)  Mallinckrodt Baker B.V., Deventer,  Netherlands 
 Chloroform/Isoamylalcohol (24:1, vol/vol)  Carl Roth GmbH & Co.KG, Karlsruhe, Germany 
 Cetyl trimethylammonium bromide (CTAB)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Citifluor  Citifluor Ltd, Leicester, UK 
 CyDye Post Labeling Reactive Dyes (Cy3/Cy5)  GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
 Diethylpyrocarbonate (DEPC)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Disodiumhydrogenphosphate dihydrate 
 (Na2HPO4*2H2O) 
 Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Dithiothreitol (DTT)  Invitrogen Corporation, Carlsbad, USA 
 EDTA disodium dihydrate  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Ethanol absolute  AustrAlco Österr. AlkoholhandelsgmbH, Spillern, Austria 
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 Ethanol denatured  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Ethidium bromide (EtBr)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Ferrous ammonium sulfate (Fe(NH4)2(SO4)2*6H2O)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Fetal Bovine Serum  MedPro GesmbH, Vienna, Austria 
 Folic acid (Pteroylglutamic acid)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Formaldehyde  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Glucose  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Glutamic acid  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Glycogen  Fermentas GmbH, St.Leon-Rot, Germany 
 HEPES (free acid)  Promega, Madison, WI, USA 
 Hydrochloric acid (HCl)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Hydroxylamine hydrochloride (NH2OH-HCl)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Isopropyl alcohol  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Magnesium sulfate heptahydrate (MgSO4*7 H20)  Merck KGaA, Darmstadt, Germany 
 N-lauryl sarcosine  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Peptone  Oxoid Ltd., Basingstoke, Hampshire, England 
 Potassiumchloride (KCl)  Merck KGaA, Darmstadt, Germany 
 PerfectHyb Hybrididzation Buffer  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Potassiumdihydrogenphosphate (KH2PO4)  Merck KGaA, Darmstadt, Germany 
 Random nonamer primers  GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
 Sheared salmon sperm DNA  Eppendorf AG, Hamburg, Germany 
 SlideHyb Glass Array Hybridization Buffer #1  Applied Biosystems/Ambion, Austin, TX, USA 
 Sodium acetate trihydrate (NaCH3COO*3H2O)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Sodium borohydride (NaBH4)  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 Sodium bicarbonat (NaHCO3)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Sodium chloride (NaCl)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Sodium dodecyl sulfate (SDS)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Sodium hydroxide (NaOH)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Soidumdihydrogenphosphate monohydrate 
 (NaH2PO4*H2O) 
 Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Sucrose  Merck KGaA, Darmstadt, Germany 
 SYBR Green II  Cambrex Bio Science Rockland, Rockland, ME, USA 
 Trichloromethane (Chloroform)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Trishydroxymethylaminomethane (Tris)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Tris/HCl  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 Trisodium citrate dihydrate  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 TRIzol  Invitrogen Corporation, Carlsbad, USA 
 Trypticase Soy Broth  Oxoid Ltd., Basingstoke, Hampshire, England 
 Yeast extract  Oxoid Ltd., Basingstoke, Hampshire, England 
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Table 6. Enzymes used 
Enzyme Company 
 BsuRI (HaeIII) restriction enzyme  Fermentas GmbH, St.Leon-Rot, Germany 
 DNase I, Amplification Grade  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 RiboLock RNase Inhibitor  Fermentas GmbH, St.Leon-Rot, Germany 
 SuperScript II RT  Invitrogen Corporation, Carlsbad, USA 
 VspI restriction enzyme  Fermentas GmbH, St.Leon-Rot, Germany 
 
 
C.5. Media and buffers 
 
All media and buffers were prepared with purified double distilled water (ddH2O) produced 
using a Milli-Q Biocel System (Millipore GmbH, Vienna, Austria) and if not stated otherwise 
were autoclaved for 20 min at 121°C and 1.013 x 105 Pa using a Varioclav 135 S H+P steam 
sterilizer. 
 
• TSY - Trypticase soy broth with yeast extract (Visvesvara 1999) 
Trypticase Soy Broth 30 g L-1 
Yeast Extract  10 g L-1 
pH 7.3 
 
• 10x PAS – Page’s amoebic saline (Page 1988) 
NaCl   1.2 g L-1 
MgSO4·7 H2O  0.04 g L-1 
CaCl2·2 H2O  0.04 g L-1 
Na2HPO4·2 H2O  1.78 g L-1 
KH2PO4   1.36 g L-1 
  
• SPG – Sucrose-phosphate-glutamate buffer – autoclaved at 110°C (15 min) 
Sucrose      75 g L-1 
KH2PO4  1.104 g L-1 
Na2HPO4*2 H2O  1.306 g L-1 
Glutamic acid  0.15 g L-1 
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• 1x TBE – Tris-borate-EDTA buffer 
Tris      10.8 g L-1 
Boric acid  5.5 g L-1 
EDTA (disodium salt) 0.93 g L-1 
pH 8.0 
 
• 1x TAE – Tris-acetate-EDTA buffer 
Tris      4.84 g L-1 
Acetic acid  1.142 mL L-1 
EDTA   0.372 g L-1 
pH 8.0 
 
• 1x TE – Tris-EDTA buffer 
Tris-HCl      1.211 g L-1 
EDTA   0.372 g L-1 
pH 8.0 
 
• 20x SSC – Sodium carbonate-sodium citrate buffer 
NaCl      175.3 g L-1 
Sodium citrate  88.2 g L-1 
pH 7.0 
 
• 1x PBS – Phosphate buffered saline 
NaCl      8 g L-1 
KCl   0.2 g L-1 
NaH2PO4   1.44 g L-1 
KH2PO4   0.24 g L-1 
pH 7.4 
 
• NNA – Non-nutrient agar 
10x PAS   100 mL L-1 
Agar   15 g L-1 
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• PYG – Peptone-yeast-glucose medium (Holdeman et al. 1977) 
Peptone      20 g L-1 
Glucose      18 g L-1 
Yeast extract     2 g L-1 
Sodium citrate     1 g L-1 
MgSO4*7 H2O     0.98 g L-1 
Na2HPO4*7 H2O     0.355 g L-1 
KH2PO4      0.34 g L-1 
Fe(NH4)2(SO4)2*6 H2O    0.02 g L-1 
pH 6.5 
 
• Remodified Chang medium (Chang 1971, modiefied by Lagkouvardos) 
Tryptone      10 g L-1 
Yeast extract     5 g L-1 
Na2HPO4*2 H2O     1.66 g L
-1
 
KH2PO4      0.8 g L
-1
 
Glucose      3 g L-1 
Liver digest     4 g L-1 
Fetal bovine serum    100 mL L-1 
 
• Modified PYNFH – Peptone-yeast-nucleic acid-folic acid-hemin (ATCC 1034) 
Bacto Peptone     10 g L-1 
Ribonucleic acid, type VI from Torula Yeast 1 g L-1 
Folic acid      0.015 g L-1 
Hemin      0.001 g L-1 
Buffer solution, pH 6.5    20 mL L-1 
(18.1 g L-1 KH2PO4, 25.0 g L-1 Na2HPO4*2 H2O) 
Fetal bovine serum    100 mL L-1 
pH 6.5 
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C.6. Cell culture 
 
C.6.1. Cultivation of P. amoebophila 
P. amoebophila UWE25 was grown axenically at a constant temperature of 20°C in a 
continuous culture with Acanthamoeba castellanii Neff as host cells. Cell cultures were 
incubated in 150 mL TSY liquid medium in 500-cm² culture flasks. Medium was exchanged 
at least once a week to achieve optimal cell growth and the state of the cultures was routinely 
monitored using an inverse microscope. 
 
C.6.2 Cell harvesting 
Amoebae were detached from the bottom surface of the culture flask by vigorous shaking. The 
suspended cells were collected in 50 mL Greiner tubes and pelleted by centrifugation (7,323 x g, 5 
min, RT). Fresh TSY medium was added to the empty culture flasks to enable growth of the 
remaining amoebae. 
 
 
C.7. Total RNA isolation 
 
All solutions used during RNA extraction were prepared with double-distilled water treated 
with 0.1% DEPC to prevent RNA degradation. 
 
C.7.1. Phenol-chloroform-extraction 
The simultaneous RNA isolation from P. amoebophila and its host was generally carried out 
using a phenol-chloroform extraction method. Infected amoebae were pelleted by short 
centrifugation (6,300 x g, 3 min, RT), resuspended in 1x PAS and counted using a Neubauer 
counting chamber. Approximately 107 cells were transferred into a microcentrifuge tube, 
pelleted again (6,300 x g, 3 min, RT) and immediately lysed by addition of 1.5 mL of the 
phenol and guanidine isothiocyanate containing reagent TRIzol that maintains the RNA 
integrity during tissue homogenization. DNA was sheared by pipetting up and down 
approximately 30 times and the TRIzol solution was transferred to a bead beater tube 
containing only one big bead and homogenized for 10 sec at a speed of 4.5 with a FastPrep 
homogenizer. Cell debris was centrifuged (13,600 x g, 5 min, RT) and the supernatant was 
transferred to a clean microcentrifuge tube and incubated at RT (5-10 min). Nucleic acids 
were extracted by addition of 0.2 volumes of chloroform to the supernatant. After vigorous 
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shaking by hand for 15 sec and incubation for 5 min at RT, the mixture was centrifuged 
(10,520 x g, 15 min, 4°C) in order to separate the phases. The aqueous phase containing the 
extracted RNA was transferred to a fresh tube and RNA was precipitated by adding 0.5 
volumes of isopropyl alcohol related to the amount of supernatant after initial 
homogenization, 0.12 volumes of 5M ammonium acetate and 1 µL of a 20 mg/mL glycogen 
solution. After incubation for 15 min at -20°C the RNA was pelleted by centrifugation 
(21,250 x g, 15 min, 4°C), washed with 1.5 mL 75% ethanol to remove salts, centrifuged 
again for 10 min and the pellet air dried for 5 min and then dissolved in 50 µL RNase-free 
water. The concentration of the RNA samples, as well as the ratio of absorbance at the 
wavelengths of 260 nm and 280 nm (ratio 260/280) and at wavelengths of 260 nm and 230 
nm (ratio 260/230), were spectrophotometrically determined. The ratio 260/280 is used as an 
easy way to assess the purity of RNA. Pure RNA should have a ratio of ~2.0. The ratio 
260/230 is an additional measure of nucleic acid purity and should be >2.0 for pure RNA. 
DNA was digested using 1U Sigma DNase 1 Amplification Grade per 2 µg of RNA for 1 h at 
RT and the reaction was stopped by addition of 1 µL Stop Solution. RNA was precipitated for 
30 min at -80°C after addition of 3 volumes of absolute ethanol, 0.1 volume of 3M sodium 
acetate (pH 5.2), and 0.01 volumes of glycogen. Then, the RNA was pelleted, washed and air 
dried as described before, and resolved in RNase-free water. RNA concentration, as well as 
the ratio 260/280 and the ratio 260/230, were determined using a NanoDrop 
spectrophotometer and the RNA was stored in the presence of RiboLock RNase Inhibitor. 
RNA quality was checked on a 1% agarose gel (as described in section C.13.) and a control 
PCR was conducted in order to verify the absence of DNA in the RNA samples (section 
C.7.3.). 
 
C.7.2. RNeasy Mini Kit 
As an alternative method for total RNA isolation the RNeasy Mini Kit (QIAGEN) was 
employed. Amoebal cells were pelleted (6,300 x g, 3 min, RT), resuspended in 1x PAS and 
counted using a Neubauer counting chamber. Approximately 107 cells were transferred into a 
microcentrifuge tube and pelleted again (6,300 x g, 3 min, RT). The pellet was resolved in 
600 µL Buffer RLT and transferred to a bead beater tube containing only one big bead and 
homogenized for 10 sec at a speed of 4.5 with a FastPrep homogenizer and 600 µL of 75% 
ethanol were added. Successively, the first 700 µL and the remaining 500 µL of the sample 
were applied to the same RNeasy Mini spin column and centrifuged (8,000 x g, 15 sec, RT). 
Then the column was washed with 700 µL Buffer RW1 (8,000 x g, 15 sec, RT) and 500 µL 
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Buffer RPE (8,000 x g, 15 sec, RT). The flow-through was discarded after each 
centrifugation. The column was transferred into a new collection tube and centrifuged again 
(21,250 x g, 1 min, RT). Then it was placed in an empty 1.5 mL collection tube and eluted 
twice with 30 µL RNase-free water (8,000 x g, 1 min, RT). RNA concentration, as well as the 
ratio 260/280 and and the ratio 260/230, were determined using a NanoDrop 
spectrophotometer and the RNA was stored in the presence of RiboLock RNase Inhibitor. 
RNA quality was checked on a 1% agarose gel (as described in section C.13.). 
 
C.7.3. Polymerase chain reaction 
Polymerase chain reaction (PCR) was performed in order to verify the absence of DNA from 
the RNA samples. For this purpose the primer set PanF/R (Table 7) that is specific for the 16S 
rRNA gene of members of the order Chlamydiales was used.  
 
Table 7. Chlamydiales specific primer set PanF/R used for 16S rDNA amplification, their 
annealing temperature (Ta) and the size of the amplicon (Corsaro et al. 2002). 
Primer name  Sequence Ta Amplicon size 
 PanF  5´-GTC ATC RGC CYY ACC TTV SRC RYY TCT-3´ 
 PanR  5´-CGT GGA TGA GGC ATG CRA GTC G-3´ 
65°C ~1 445 bp 
 
One PCR reaction (50 µL) was constituted of following components and 1 µL of RNA 
sample: 
 
PCR Reaction (50 µL) 
MgCl2       4 µL 
10x Reaction Buffer     5 µL 
dNTP mix      5 µL 
Taq polymerase      0.2 µL 
Forward primer (100 pmol µL-1)   0.25 µL 
Reverse primer (100 pmol µL-1)    0.25 µL 
ddH2O     35.3 µL 
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A positive and a negative control were included in each PCR. Following PCR program was 
used for the amplification of 16S rRNA gene fragments: 
 
PCR Program for 16S PCRs (PanF/R) 
Cycle  1 (1x):  
 Step  1:  95.0ºC for 03:00 
Cycle  2 (30x):  
 Step  1:  95.0ºC for 00:30 
 Step  2:  65.0ºC for 00:30 
 Step 3:  72.0°C for 01:30 
Cycle  3 (1x):  
 Step  1:  72.0ºC for 07:00 
Cycle 4 (1x): 
 Step 1: 22.0°C HOLD 
 
 
C.8. Bacterial RNA enrichment 
 
The MICROBEnrich Kit was deployed to enrich the isolated total RNA sample in chlamydial 
RNA. The kit removes undesired eukaryotic RNA – both mRNA and rRNA – by capturing 
them with complementary oligonucleotide probes that are themselves captured by magnetic 
beads and removed from the solution using a magnet. 
 
At first, the total RNA was precipitated (3 volumes absolute ethanol, 0.1 volume 3M sodium 
acetate, 5 µg glycogen) for 30 min at -80°C or over night at -20°C and pelleted by 
centrifugation (21,250 x g, 30 min, 4°C). The pellet was washed in 75% ethanol (21,250 x g, 
10 min, 4°C), air dried and resuspended in 35 µL 1x TE buffer. 5 µL were put aside for 
agarose gel electrophoresis. The RNA sample was mixed with 300 µL Binding Buffer and 2 
µL of Capture Oligo Mix per 5 µg RNA and incubated for 10 min at 70°C and 1 h at 37°C. 
During the incubation time the Oligo MagBeads were prepared (25 µL Oligo MagBeads per 5 
µg of input RNA). They were captured on the magnetic stand, washed with nuclease-free 
water, washed with Binding Buffer, and kept on ice until 5 min before use when they were 
placed at RT. After incubation of the sample the beads were added and the mixture was 
incubated for 15 min at 37°C. The beads were captured on the magnetic stand and the 
supernatant was transferred to a collection tube on ice. 100 µL Wash Solution (prewarmed to 
37°C) were added to the beads and after 5 min of incubation at 37°C, the beads were captured 
again and the supernatant was pooled with the RNA already in the collection tube. 
Subsequently the enriched bacterial RNA was precipitated (2.5 volumes absolute ethanol, 0.1 
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volume 3M sodium acetate, 20 µg glycogen) at -20°C for 1 h, centrifuged (21,250 x g, 30 
min, 4°C), washed with 750 µL ice cold 75% ethanol, centrifuged again for 10 min and the 
pellet was air dried and resuspended in 35 µL RNase free water. Again, 5 µL were put aside 
for the gel, the RNA concentration was measured and the 5 µL samples taken before and after 
the MICROBEnrich procedure were subjected to agarose gel electrophoresis to confirm the 
successful enrichment. The Oligo MagBeads were regenerated to be used a second time. 
Regeneration was done by washing the beads with 2 volumes Regeneration Solution 1 and 
washing twice with Regeneration Solution 2. The beads were stored in 1 volume 
Regeneration Solution 2. All solutions that were not provided with the kit were prepared with 
double-distilled water treated with 0.1% DEPC to prevent RNA degradation. 
 
 
C.9. Aminoallyl labeling 
 
In order to measure gene expression with a microarray, the RNA sample has to be reversely 
transcribed into cDNA labelled with a fluorescent dye. This can be achieved by initially 
incorporating aminoallyl nucleotides during reverse transcription into the cDNA to which the 
fluorescent dye is then coupled in a second step. Indirect labeling of total RNA was 
performed based on a protocol described in Mäurer et al. 2007. 
 
C.9.1. Reverse transcription 
To an RNA sample containing 20 µg of total RNA or 5 µg of enriched RNA 1 µL of random 
nonamer primers was added and filled up with DEPC-treated ddH2O to a volume of 11 µL 
(reaction volume increased with low RNA concentrations). To allow annealing of the primers, 
the reaction was incubated at 65°C for 10 min and cooled down for 5 min at RT and for 5 min 
on ice. Then a reverse transcription master mix was added, containing 4 µL 5x First Strand 
Buffer, 2 µL 0.1M DTT, 2 µL nucleotide mix (Table 8) and 1.5 µL SuperScript II RT 
200U/µL per 9.5 µL. Reverse transcription reaction took place on 42°C over night. The 
remaining RNA was hydrolyzed by addition of 5 µL 2.5M sodium hydroxide and incubation 
for 15 min at 37°C. 10 µL of 2M HEPES (pH 7) were added to neutralize the pH and the 
cDNA was purified by ethanol precipitation (addition of 150 µL absolute ethanol and 6 µL 
3M sodium acetate) at -20°C o/n. The precipitated aa-cDNA  was pelleted (21,250 x g, 30 
min, 4°C), washed with 75% ethanol, centrifuged  (21,250 x g, 10 min, 4°C) and the pellet air 
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dried and resuspended in 17.5 µL 0.1M sodium bicarbonate buffer (pH 9) and the DNA 
concentration was measured. 
 
Table 8. Different nucleotide mixes used for reverse transcription. 
Nucleotide mix Concentration of  dATP/dCTP/dGTP 
Concentration 
of dTTP 
Concentration 
of aa-dUTP 
Preliminary nucleotide mix 6.0 mM 0.8 mM 5.0 mM 
1:2-nucleotide mix 6.0 mM 2.0 mM 4.0 mM 
2:1-nucleotide mix 6.0 mM 4.0 mM 2.0 mM 
3:2-nucleotide mix 6.0 mM 1.8 mM 1.2 mM 
4:3-nucleotide mix 6.0 mM 1.7 mM 1.3 mM 
1:1-nucleotide mix 6.0 mM 3.0 mM 3.0 mM 
 
C.9.2. Coupling of aminoallyl-cDNA to the fluorescent dye 
The aa-cDNA was coupled to a CyDye ester (Cy3 or Cy5) by mixing the resuspended cDNA 
in one tube CyDye and incubating in the dark. After 2 h, 7.5 µL 4M hydroxylamine were 
added, and the incubation was continued for 15 min. 
 
C.9.3. Purification of labelled cDNA 
Finally, the labelled cDNA was purified using the PCR Purification Kit. 5x reaction volume 
Buffer PB was added to the sample and the mixture was transferred to a QIAquick column 
placed in a 2 mL collection tube. After centrifugation (18,890 x g, 1 min, RT) the column was 
washed with 750 µL Buffer PE (18,890 x g, 1 min, RT) and dried by centrifugation (21,250 x 
g, 1 min, RT). The column was placed in a new 1.5 mL tube and the DNA was eluted twice 
with 30 µL ddH2O (18,890 x g, 1 min, RT) to an end volume of 60 µL. 
 
C.9.4. Calculation of labeling parameters 
The samples were then photospectrometrically measured. From the absorption maxima at 
wavelengths of 550 nm for Cy3 or 650 nm for Cy5 and 260 nm for DNA, the amount of 
CyDye and cDNA, as well as the frequency of incorporation (FOI) that describes the number 
of incorporated labeled nucleotides per 1000 nucleotides of cDNA, were calculated.  
 
The formula used for calculating the amount of CyDye in the sample is derived from the 
Beer-Lambert equation ( cbEA ××= , where A is the absorbance, E the extinction 
coefficient [L mol-1 cm-1], b the path length [cm], and c the analyte concentration [mol L-1]): 
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bE
vA
pmolCyDye
×
××
=
610)(  
A… absorbance in absorbance units at 550 nm for Cy3, at 650 nm for Cy5 
v … volume in µL 
E… extinction coefficient in [L mol-1 cm-1]; E = 150,000 for Cy3, E = 250,000 for Cy5 
b … path length in cm (NanoDrop measurements are normalized to a path length of 0.1 cm) 
 
For nucleic acid quantification, the Beer-Lambert equation is modified to use an extinction 
coefficient with units of [ng cm ml-1]: 
b
veA
µgcDNA ××=)(  
A… absorbance in absorbance units at 260 nm 
e … extinction coefficient in [µg cm mL-1]; e = 37 for Cy-labelled cDNA 
v … volume in mL 
b … path length in cm (NanoDrop measurements are normalized to a path length of 0.1 cm) 
 
From these two values, the FOI can be calculated: 
][
000,1][5.324][ 1
µgcDNA
molgpmolCyDyeFOI ××=
−
 
 324.5 g mol-1 … average molecular weight of a deoxynucleotide 
 
 
C.10. cDNA amplification and direct labeling 
 
In order to enhance the performance of RNA samples enriched with MICROBEnrich (see 
section C.8.) an amplification step was introduced before the fluorescent labeling of the 
cDNA. For this purpose the enriched RNA samples were reversely transcribed as described in 
section C.9.1 with the exception that a dNTP mix (6mM dATP/dCTP/dGTP/dTTP) without 
aminoally-dNTPs was used and the cDNA was finally resuspended in 17.5 µL ddH2O instead 
of sodium bicarbonate. 
 
C.10.1. cDNA amplification 
The illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare) was used for cDNA 
amplification. The kit utilizes the DNA polymerase of bacteriophage Phi29 to exponentially 
amplify linear DNA templates by a strand displacement reaction. 
 
As a template, 1 µL of cDNA was mixed with 9 µL of sample buffer (containing random 
hexamers that nonspecifically prime Phi29 DNA polymerase catalyzed polymerization). The 
  C. Materials and Methods 
 29 
sample was then denatured at 95°C for 3 min and cooled to 4°C on ice. In the meantime the 
GenomiPhi Kit reaction mix was prepared by combining 9 µL of reaction buffer (containing 
salts and deoxynucleotides) with 1 µL of enzyme mix. The reaction mix was then added to the 
cool sample and the mixture was incubated on 30°C over night (16 h). After amplification the 
polymerase was heat-inactivated at 65°C for 10 min. 
 
C.10.2. Restriction enzyme digestion of amplified cDNA 
Most DNA generated by GenomiPhi is of high molecular weight and therefore not suitable for 
microarray hybridization. Thus, the amplified cDNA was subjected to a restriction enzyme 
digestion with the enzyme BsuRI. BsuRI is a 4 base pair cutter that cuts at the recognition 
sequence 5'-GG^CC-3', thereby generating fragments of an average length of 256 base pairs. 
 
The restriction digestion reaction, consisting of 17.5 µL of the GenomiPhi-amplified cDNA, 
3.0 µL of the restriction enzyme BsuRI (10 U µL-1), 3.0 µL of 10x Buffer R, and 6.5 µL 
ddH2O, was incubated for 4 h on 37°C. The reaction was stopped by heat inactivation at 80°C 
for 20 min. 
 
C.10.3. Purification of amplified cDNA 
Before labeling, the amplified cDNA has to be purified to remove all the components of the 
amplification and the restriction enzyme digestion. For this purpose the QIAquick Nucleotide 
Removal Kit was used. 5 volumes of Buffer PN were added to the sample containing the 
amplified cDNA. The mixture was applied to a QIAquick spin column in a 2 mL collection 
tube. After centrifugation (3,824 x g, 1 min, RT), the flow-through was discarded, the column 
washed with 750 µL of Buffer PE (3,824 x g, 1 min , RT) and the flow-through was again 
discarded. Subsequently the column was dried by centrifugation (18,890 x g, 1 min, RT) and 
placed into a clean 1.5 µL microcentrifuge tube. The DNA bound to the column was eluted 
two times with 25 µL ddH2O (18,890 x g, 1 min, RT). 
 
C.10.4. Direct labeling of amplified cDNA 
For labeling of the amplified cDNA the same protocol was used as for the labeling of 
genomic DNA (described in section C.12.). 
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C.11. Genomic DNA isolation 
 
Genomic DNA was isolated according to a protocol described in (Zhou et al. 1996). Cells 
were harvested (7,232 x g, 5 min, RT), washed with 1x PAS and centrifuged as before. The 
pellet was resuspended in 250 µL TE buffer. 675 µL DNA extraction buffer (100mM 
Tris/HCl, 100mM EDTA, 100mM sodium phosphate, 1.5mM sodium chloride, 1% CTAB, 
200 µg mL-1 proteinase K) were added and after incubation at 37°C for 30 min 75 µL of 20% 
SDS were added and incubation was continued at 65°C for 2 h, inverting the sample gently 
every 20 min. Then the sample was mixed with an equal volume of 
chloroform/isoamylalcohol, centrifuged (10,600 x g, 10 min, RT) and the aqueous phase was 
transferred into a new microcentrifuge tube. Nucleic acids were precipitated by addition of 0.6 
volumes of isopropanol for 1 h at RT and pelleted (16,000 x g, 20 min, RT). The pellet was 
washed with ice-cold 75% ethanol (21,250 x g, 5 min, RT), resuspended in ddH2O and he 
concentration was measured using NanoDrop. Subsequently the DNA was fragmented by 
sonication and fragment sizes were mainly ranging between 500 bp and 1,500 bp. 
 
 
C.12. Direct labeling of genomic DNA 
 
The protocol utilizes the DecaLabel DNA Labeling Kit (Fermentas) but with several 
modifications. For one labeling reaction 2 µg of template DNA were combined with 10 µL of 
5x reaction buffer (containing decanucleotides for random priming) and filled with ddH2O to 
45 µL. The sample was denatured at 95°C for 10 min and immediately put on ice. Then 1 µL 
of dNTP mix (2mM dCTP, 5mM dATP/dTTP/dGTP), 2 µL of Cy-dCTP (1mM) and 0.8 µL 
of Klenow (50 U µL-1) were added. The labeling reaction was incubated for 2.5 hours at 
37°C. After 90 min, 4 µL of the dNTP mix delivered with the kit were added. After the 
incubation the labeling was purified using the QIAquick Nucleotide Removal Kit as described 
in section C.10.3. and measured with NanoDrop. Since the genomic DNA labeled according 
to this protocol consists of both labeled and unlabeled sense and antisense strands, meaningful 
incorporation rates could not be calculated. 
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C.13. Agarose gel electrophoresis 
 
1% agarose gels were poured after dissolving 1 g of Biozym LE Agarose in 100 mL of TBE 
or TAE buffer for DNA or RNA gels, respectively, by short heating in the microwave. For 
2.5% agarose gels, 2.5 g agarose were used. The gels were run using Sub-Cell GT Systems in 
combination with PowerPac Basic Power Supplies for approximately 1-2 h on 100-120 Volts. 
DNA gels were stained with ethidium bromide, RNA gels with SYBR Green II for 1 h. The 
staining was visualized using a BioView UV transilluminator with the ArgusX1 V.4 software. 
 
 
C.14. Microarray fabrication 
 
The microarray was constructed from 5’-amino modified oligonucleotide probes obtained 
from Microsynth (Microsynth GmbH, Balgach, Switzerland) that were printed onto silylated 
amine-aldehyde glass slides (VSS-25C, CEL Associates) using a BioRobotics MicroGrid 
610/TAS system equipped with 16 MicroSpot 2500 split pins (Zinsser Analytic GmbH). A 
maximum of 80 spots were printed per source visit, including 20 spots on pre-spotting slides 
to avoid printing excess material from the external surface of the pin onto the actual 
microarray slides. Spots after pre-spotting were about 150 µm in diameter and spot centres 
were about 300 µm apart. To minimize carry-over effects the pins were subjected to 6 wash 
cycles between each oligonucleotide spotted. The relative humidity within the spotting 
compartment was set to 50% during the spotting.  
 
 
C.15. Post processing of microarray slides 
 
The spotted slides were allowed to rest for one day at 100% humidity to increase covalent 
coupling between the aminated 5’-ends of the oligonucleotides to the aldehyde groups on the 
slide surface. To deactivate uncoupled aldehyde groups and to remove salts and unbound 
DNA the slides were washed twice under vigorous agitation in 0.2% SDS for 2 min and twice 
in double-distilled water for 2 min. After air drying for 5 min the slides were incubated in 
freshly prepared sodium borohydride solution (0.6 g NaBH4 in 200 mL PBS and 60 mL of 
absolute ethanol) for 5 min to further strengthen the coupling linkages and to convert reactive 
aldehyde groups into non-reactive alcohol counterparts thereby reducing non-specific 
attachment of molecules to the microarray surface during hybridization (Schena 2003). The 
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reaction was stopped by dipping in ice cold absolute ethanol and the slides were washed twice 
under vigorous agitation in 0.2% SDS for 1 min and twice in double-distilled water for 1 min. 
Finally the slides were dried by centrifugation (289 x g, 2 min, RT) and stored in the dark. All 
steps were carried out at room temperature. 
 
 
C.16. Spotting quality assessment 
 
Hybridization with labeled poly-dTTP probes 12 nucleotides in length targeting the A-spacers 
of the printed oligonucleotides was used as an assessment of the spotting quality to detect 
spotting failures and as a fast and inexpensive way to investigate the effects of altered post-
processing or hybridization conditions. Per hybridization 15 µL of a 1pM poly-dTTP probe 
solution were resuspended in 400 µL of hybridization buffer (5x SSC, 0.02% SDS, 0.1% N-
lauryl sarcosine; 0.1% blocking reagent). The mixture was applied to the spotted slides using 
sealed coverslips and incubated at 30°C for 1 h under vigorous shaking at 400 rpm. To stop 
the hybridization, slides were rinsed two times in ice-cold double-distilled water for 2 min 
and dried by centrifugation (289 x g, 2 min, RT).  
 
 
C.17. Prehybridization 
 
To block and inactivate non-specific binding sites in order to reduce the background in 
following hybridizations the slides were incubated in a sterile-filtrated and preheated 
prehybridization solution (5x SSC, 0.1% SDS, and 1% bovine serum albumin [BSA]) 
immediately prior to hybridization for at least 1 h at 42°C (Hegde et al. 2000). Slides were 
washed at RT, two times in double-distilled water for 2 min, followed by washing in 
isopropanol for another 2 min, and dried by centrifugation (289 x g, 2 min, RT). 
 
 
C.18. Hybridization and washing conditions 
 
The key to successful hybridization results is the balance between signal intensity and 
specificity. The optimal stringency during hybridization and washing was experimentally 
determined in order to maximize the signal intensity and minimize cross-hybridization 
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(Haider, unpublished). Stringency can be adjusted by the formamide concentration in the 
hybridization buffer, hybridization temperature, salt concentration in the wash buffers, and 
washing temperature (Wildsmith et al. 2001). 
 
C.18.1. Hybridization buffers 
For most hybridizations in this study a self-made hybridization buffer was used that was 
prepared as follows: 
       final concentration 
 20x SSC   250 µL 5x SSC 
 10% SDS     10 µL 0.1% SDS 
 0.1M DTT       1 µL 100 µM DTT 
 10% N-laurylsarcosine   10 µL 0.1 % N-laurylsarcosine 
 10% blocking reagent 100 µL 1% blocking reagent 
 formamide   350 µL 35% formamide 
 ddH2O    279 µL ad 1 mL with ddH2O 
 
The hybridization solution was filtered through a 0.45 µm filter and 15 µL sheared salmon 
sperm DNA were added to block unspecific binding positions in order to reduce unspecific 
signals. Before application to the microarray slide, the hybridization solution was mixed with 
the labeled sample and heated to 95°C for 10 min to completely denature the cDNA and 
remove any secondary structures. 
 
Alternatively, two commercially available hybridization buffers were tested: PerfectHyb 
Hybridization Buffer obtained from Sigma and SlideHyb Glass Array Hybridization Buffer 
#1 obtained from Ambion. Both buffers were used according to manufacturer’s instruction. 
 
C.18.2. Hybridization system 
Hybridization was performed using HybriWell FL Sealing Systems. 400 µL of hybridization 
buffer containing the labeled sample were applied to the prehybridized slide via the 
HybriWell, or, when the PerfectHyb buffer was used, directly onto the slide, due to the 
buffer’s high viscosity. Slides were incubated at 42°C for 16 h under constant shaking using a 
ThermoTWISTER comfort (Quantifoil Instruments GmbH). 
 
 
C. Materials and Methods 
 34 
C.18.3. Washing procedures 
After hybridization, the slides were washed with buffers of increasing stringencies that were 
preheated to 42°C. Stringencies were adjusted by the concentration of SSC and SDS in the 
wash buffers. Washing was performed by putting up to two slides into one Greiner tube 
containing 50 mL of the respective wash buffer and shaking it constantly for 2.5 min, then 
quickly changing the slides into the next Greiner tube and so on. After the washing steps the 
slides were dipped briefly in ice cold water and dried by centrifugation (289 x g, 2 min, RT). 
Different washing procedures were used for different hybridization buffers. 
 
Standard washing procedure (for self-made hybridization buffer): 
2x low stringency wash buffer:  2x SSC, 0.1% SDS 
2x medium stringency wash buffer:  0.1x SSC, 0.1% SDS 
2x high stringency wash buffer:  0.1x SSC 
 
More stringent washing procedure (for PerfectHyb buffer): 
2x low stringency wash buffer:  0.2x SSC, 0.1% SDS 
2x medium stringency wash buffer:  0.1x SSC 
2x high stringency wash buffer:  0.05x SSC 
 
Static washing procedure (for SlideHyb buffer): 
No shaking was involved in this procedure. The slides were just put in tubes with the washing 
buffers and incubated for 15 min in the water bath on 42°C. 
2x low stringency wash buffer:  2x SSC, 0.5% SDS 
2x high stringency wash buffer:  0.5x SSC, 0.5% SDS 
 
 
C.19. Microarray scanning, signal quantification and data analysis 
 
Microarrays were scanned using a GenePix 4100 (Axon Instruments). Initial visualization and 
data analysis was carried out using the GenePix Pro 5.0 software. A circle was drawn around 
each spot and the mean intensity of signal within the spot and of the local background area 
was calculated. The signal-to-noise ratio (SNR) that was used to discriminate true signals 
from noise was calculated as follows: 
SNR = (signal mean – background mean) / (background standard deviation). 
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The commonly accepted criterion for the minimum signal (threshold) that can be accurately 
quantified is SNR≥3 (Verdnik et al. 2002) and this threshold was also used in this study. For 
further analysis, microarray data were transferred to Microsoft Excel. 
 
 
C.20. Amoeba isolation 
 
Free-living amoebae are ecologically important protozoa that are ubiquitously abundant in the 
environment and can be readily isolated from almost any soil samples. 
 
C.20.1. Sample acquisition 
Samples were taken in Feldkirch (Vorarlberg) in August 2008 in sterile 50 mL Greiner tubes: 
 
Sample A: Soil taken from a molehill in my garden 
Sample B: Sediment from the shores of a quarry lake 
 
Samples were stored aerobically at 4°C for 2 days until start of isolation. 
 
C.20.2. Extraction of amoebae on non-nutrient agar 
For each sample, three replicate extractions were performed. Amoebae were extracted by 
applying sample to the middle of non-nutrient agar (NNA) plates seeded with living 
Escherichia coli K12. After a few days, amoebae had moved from the soil sample deposited 
in the middle of the plate towards the periphery, feeding on the bacterial cells. A piece of agar 
occupied with amoebae was cut out and under sterile conditions transferred to new NNA 
plates with living E. coli, a process that was repeated every 3 to 6 days. After 5 rounds of 
plate transfer the living E. coli cells were replaced with dead E. coli (heat inactivation for 1 h 
at 95°C) as a food source in order to cautiously prepare the amoebae for axenization. After 
three rounds on NNA plates with dead E. coli, cut out pieces of agar were inoculated in 25 
cm2 culture flasks containing 10 mL of PYG medium. When the amoebal cells were attached 
to the surface of the flask, the medium was replaced by 10 mL 1x PAS to trigger encystation 
by starvation. When most amoebae had formed cysts, the PAS was replaced by 0.2M 
hydrochloric acid (HCl), triggering the amoebae to excyst and at the same time killing all 
potential extracellular bacterial contaminations. After HCl-treatment for 10 min, the flasks 
were washed with 10 mL 1x PAS and then incubated with 10 mL PYG and supplementary 
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administration of dead E. coli. The medium in the culture flasks was regularly replaced and 
the amount of dead E. coli was reduced each time until none were added at all. Since the 
amoebae did not grow well, PYG was replaced by the richer media Chang and PYNFH later 
on. 
 
C.20.3. Staining with 4',6-diamidino-2-phenylindole (DAPI) 
 
In order to detect intracellular bacteria the amoeba cells were stained with 4’,6-diamidino-2-
phenylindole (DAPI). DAPI is a fluorescent dye that binds strongly to AT-rich sequences in 
ribonucleic acids. Its absorption maximum is at 365 nm and its emission maximum is at 418 
nm. 15 µL of an amoeba solution were applied on a microscopic slide. After allowing the 
attachment of the amoebae on the surface, the cells were stained with 10 µL of a DAPI 
working solution (0.1 µg/mL). After 5 min incubation in the dark they were washed with MQ, 
air dried, and embedded in Citifluor and the staining was visualized with an epifluorescence 
microscope. 
 
C.20.4. Fluorescence in situ hybridization 
Fluorescence in situ hybridization (FISH) was conducted to verify the presence of 
endosymbionts within the isolated amoebae. 10 mL amoeba culture was harvested (7,232 x g, 
5 min, RT), washed with 500 µL and resuspended in 200 µL 1x PAS. The amoeba suspension 
was applied to a microscopic slide (20 µL per reaction well). After attachment of the amoebae 
to the surface, the supernatant was aspirated off and the cells were fixed with 10 µL 4% 
formaldehyde for 10 min. Then the cells were washed with 20 µL ddH2O and air dried. 1 mL 
of hybridization buffer (180 µL 5M NaCl, 20 µL 1M Tris/HCl, 599 µL ddH2O, 200 µL 
formamide, 1 µL 10% SDS) was prepared and 10 µL of buffer were applied to each well. The 
hybridization buffer contains 20% formamide to adjust the stringency level required for 
specific binding of the probes. Then 1 µL of each of the oligonucleotide probe solutions 
(Table 9) was added and the slide was placed horizontally into a Greiner tube containing a 
tissue paper soaked in the remaining hybridization buffer. This hybridization chamber was 
incubated at 46°C for 90 min. After hybridization the slide was washed in a Greiner tube 
containing 50 mL washing buffer (2.15 mL 5M NaCl, 1mL 1M Tris/HCl, 0.5 mL 0.5M 
EDTA, 46.35 mL ddH2O; preheated to 48°C) for 15 min at 48°C. The concentration of 
sodium chloride in the washing buffer confers stringency upon the washing procedure, 
equivalent to formamide used during hybridization. After washing, the slide was dipped 
  C. Materials and Methods 
 37 
briefly into ice-cold ddH2O, dried as quickly as possible using compressed air and embedded 
in Citifluor. The cells were visualized and pictures were taken on a confocal laser scanning 
microscope (CLSM). 
 
Table 9. FISH probes used. EUB338 (Amann et al. 1990), Chls-0523 (Poppert et al. 2002), 
BET42a (Manz et al. 1992), and ALF968 (Neef 1997) were used to detect the domain 
Bacteria, the order Chlamydiales, and the classes Betaproteobacteria and 
Alphaproteobacteria, respectively. To exclude unspecific binding the nonsense probe 
NONEUB (Wallner et al. 1993) was used. Oligonucleotide sequences and target groups 
(including coverage) are shown. ProbeBase (Loy et al. 2007) accession numbers are pB-
00159 (EUB338), pB-00049 (Chls-0523), pB-00034 (BET42a), pB-00021 (ALF968) and pB-
00243 (NONEUB). All probes were used at a formamide concentration of 20%. 
 Probe name  Sequence  Target group 
 EUB338  5'- GCT GCC TCC CGT AGG AGT -3'  Most bacteria (90% coverage) 
 Chls-0523  5'- CCT CCG TAT TAC CGC AGC -3'  Chlamydiales (93% coverage) 
 BET42a  5'- GCC TTC CCA CTT CGT TT -3'  Betaproteobacteria (93% coverage) 
 ALF968  5'- GGT AAG GTT CTG CGC GTT -3'  Alphaproteobacteria (79% coverage) 
 NONEUB  5'- ACT CCT ACG GGA GGC AGC -3'  Control complementary to EUB338 
 
C.20.5. DNA isolation 
DNA was isolated using the DNeasy Blood and Tissue Kit (QIAGEN). The cells were 
harvested by centrifugation (7,232 x g, 5 min, RT), the pellet was washed with 1x PAS (7,232 
x g, 5 min, RT) and then resuspended in 180 µL lysis Buffer ATL. 20 µL of proteinase K 
were added and the sample was thoroughly mixed by vortexing and incubated at 56°C for 1 h 
under constant shaking. To the viscous lysate 200 µL Buffer AL and 200 µL of absolute 
ethanol were added and vortexed until a homogeneous solution was obtained. This mixture 
was pipetted into a DNeasy Mini spin column placed in a 2 mL collection tube. After 
centrifugation (6,940 x g, 1 min, RT), the column was washed with 500 µL Buffer AW1 
(6,940 x g, 1 min, RT) and 500 µL Buffer AW2 (21,250 x g, 3 min, RT). Flow-through and 
collection tube were discarded after each centrifugation step. Then the column was placed 
into a clean 1.5 mL microcentrifuge tube and the DNA was eluted twice (6,940g, 1 min, RT) 
with 100 µL ddH2O to an end volume of 200 µL. The concentration of the isolated DNA was 
determined using NanoDrop. 
C. Materials and Methods 
 38 
C.20.6. Polymerase chain reaction 
Polymerase chain reaction (PCR) was used for amplification of 18S and 16S rRNA genes in 
order to identify the isolated amoebae and their endosymbionts, respectively. One PCR 
reaction (50 µL) was constituted of following components and 1-2 µL of template DNA: 
 
PCR reaction (50 µL) 
MgCl2           4 µL 
10x Reaction Buffer      5 µL 
dNTP mix        5 µL 
Taq polymerase       0.2 µL 
Forward primer, 100 (50) pmol µL-1    0.25 (0.5 µL) 
Reverse primer, 100 (50) pmol µL-1    0.25 (0.5 µL) 
ddH2O      35.3 (34.8 µL) 
 
The PCR programs that were used for amplification with 16S primers (Table 10) and 18S 
primers (Table 11) are shown below: 
 
PCR Program for 16S PCRs (PanF/R) 
Cycle  1 (1x):  
 Step  1:  95.0ºC for 03:00 
Cycle  2 (30x):  
 Step  1:  95.0ºC for 00:30 
 Step  2:  65.0ºC for 00:30 
 Step 3:  72.0°C for 01:30 
Cycle  3 (1x):  
 Step  1:  72.0ºC for 07:00 
Cycle 4 (1x): 
 Step 1: 22.0°C HOLD 
 
PCR Program for 18S PCRs (SSU1, SSU2, 18S-786f, 18S-893r) 
Cycle  1 (1x):  
 Step  1:  95.0ºC for 03:00 
Cycle  2 (30x):  
 Step  1:  95.0ºC for 00:30 
 Step  2:  50.0ºC for 00:30 
 Step 3:  72.0°C for 01:30 
Cycle  3 (1x):  
 Step  1:  72.0ºC for 07:00 
Cycle  4 (1x): 
 Step 1: 22.0°C HOLD 
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Table 10. Chlamydiales specific primer set PanF/R used for 16S rDNA amplification, 
their annealing temperature (Ta) and the size of the amplicon (Corsaro et al. 2002) 
 Primer name  Sequence Ta Amplicon size 
 PanF  5´-GTC ATC RGC CYY ACC TTV SRC RYY TCT-3´ 
 PanR  5´-CGT GGA TGA GGC ATG CRA GTC G-3´ 
65°C ~1 445 bp 
 
 
Table 11. Acanthamoeba specific primers used for 18S rDNA amplification, annealing 
temperatures (Ta) and respective amplicon sizes (Gast et al. 1994; Fahrni et al. 2003) 
 Primer name  Sequence Ta Amplicon size 
 SSU1  5'-AAC CTG GTT GAT CCT GCC AGT-3´ 
 18S-893r  5'-AAG TTT CAG CCT TGC GAC CA-3´ 
50°C ~1400 bp 
 18S-786f  5'-GAT YAG ATA CCG TCG TAG TC-3´ 
 SSU2  5'-GAT CCT TCT GCA GGT TCA CCT AC-3´ 
50°C ~1000 bp 
 
 
C.20.7. Sequencing of PCR products 
The PCR products were purified using the QIAquick PCR Purification Kit as described in 
section C.9.3. and the purified PCR products were sequenced with an ABI 3130x Genetic 
Analyzer (Applied Biosystems). The same primers were used for sequencing as were used for 
amplification with one exception: no viable sequence could be obtained using primer PanR, 
so it was replaced with primer 781F (5’-AACAGGATTAGATAC-3’) for the 16S rRNA gene 
sequencing. 
 
C.20.8. Sequence analysis 
Sequences were manually corrected using the FinchTV software and identified using the basic 
local alignment search tool BLAST (Altschul et al. 1990) to compare them with sequences in 
the database of the National Center for Biotechnology Information (NCBI). The alignment of 
the obtained 16S rRNA and 18S rRNA sequences, as well as the calculation of phylogenetic 
trees was performed using the ARB software package (Ludwig et al. 2004). 
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D. Results 
 
D.1. RNA isolation 
 
In order to obtain large amounts of RNA for the optimization of the microarray, 20 culture 
flasks (500 cm²) containing A. castellanii Neff infected with P. amoebophila UWE25 were 
harvested (section C.6.2.) and the total RNA was isolated using phenol-chloroform-extraction 
(section C.7.1.). 
 
The concentration of the RNA samples, as well the ratio 260/280 and the ratio 260/230, were 
spectrophotometrically determined (Table S2). Before DNase digestion, the 260/280 values of 
the isolated RNA were ranging between 1.05 and 2.06 ( x = 1.56), the 260/230 values between 
0.92 and 1.39 ( x = 1.20), indicating the presence of considerable amounts of contaminants, 
probably phenol and other carryover from the isolation procedure. To remove potential 
contaminating DNA, DNase digestion was carried out. The DNA digestion protocol also 
contains an additional purification step that should help to remove phenol and other 
contaminants. 
 
Spectrophotometric measurements of the samples were taken again after DNase digestion 
(Table S2). A total of 4,565 µg RNA was extracted from 20 culture flasks (228 µg per flask). 
The 260/280 ratios were ranging between 2.06 and 2.14 ( x = 2.12) and the 260/230 ratios 
were ranging between 2.26 and 2.42 ( x = 2.36), indicating sufficient RNA purity. RNA 
quality was assessed on an agarose gel (section C.13., Figure 3A) and a control PCR (section 
7.3.) was performed to verify the absence of DNA after digestion and no product was 
obtained for any of the isolated RNA samples (Figure 3B).  
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Figure 3. (A) Agarose gel of isolated RNA samples. Lane 1 and 21: RiboRuler RNA ladder, 
high range; lanes 2-20, 22-27: DNase digested RNA samples (DD01-DD25). Strong bands 
that are visible correspond to ribosomal RNA, the fastest running fragments correspond to 
small RNAs and possibly degraded RNA, mRNA populations are visible only as a smear. (B) 
Control PCR with isolated RNA samples and PanF/R primers. Lane 1 and 29: GeneRuler 
1kb; lanes 2-26: DNase digested RNA samples (DD01-DD25); lane 27: positive control 
(DNA from UWE25 from the American Type Culture Collection ATCC, accession number 
PRA-7); lane 28: negative control (ddH2O). No bands are present except for the PCR product 
obtained from the positive control. 
 
RNA from this isolation was used for most experiments conducted in this study. For the 
cDNA amplification experiment, however, additional RNA was isolated. There, the TRIzol-
chloroform-extraction (section C.7.1.) was compared to the RNA isolation with the RNeasy 
Mini Kit (section C.7.2.). Four large culture flasks containing A. castellanii Neff infected with 
P. amoebophila UWE25 were harvested (section C.6.2.) and 2 x 107 cells were used in each 
protocol. The yield of the TRIzol-chloroform-extraction protocol was higher than that of the 
RNeasy Kit (Table 12) and small RNA fragments were considerably more abundant (Figure 
4), since with the RNeasy procedure, only RNA molecules longer than 200 nucleotides are 
purified and small RNAs, such as 5.8S rRNA, 5S rRNA, and tRNAs, are selectively excluded. 
A PCR to verify the DNA digestion was not performed since small amounts of residual DNA 
would not interfere with the experiment. 
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Table 12. RNA isolated with TRIzol-chloroform and RNeasy Kit.  
Sample Concentration Volume RNA amount Ratio 260/280 
Ratio 
260/230 
RNA-TRI 3382.3 ng/µL 200 µL 676 µg 2.02 2.01 
RNA-easy 1353.4 ng/µL 200 µL 271 µg 2.14 1.73 
 
 
 
 
 
D.2. Bacterial RNA enrichment 
 
A major challenge in studying the gene expression of intracellular bacteria is the low 
abundance of bacterial mRNA in comparison to the RNA of the host organism and the 
ribosomal RNA fraction, because all non-target RNA species are labeled alongside the target 
RNA and contribute to high background and low signal intensities. Separation of bacterial 
RNA from the total RNA population might therefore be advantageous and was carried out 
using the MICROBEnrich Kit. This kit removes polyadenylated eukaryotic mRNA as well as 
18S and 28S rRNA by capturing them with complementary oligonucleotide probes that are 
themselves captured by magnetic beads and removed from the solution using a magnet 
(section C.8.). After application of the kit the samples were considerably depleted in overall 
RNA (Figure 5) and presumably enriched in chlamydial RNA. The protocol reduced the 
overall amount of RNA to an average of 16.4% of total starting RNA (Table S3).  
 
Figure 4. Agarose gel of isolated RNA samples. Lane 1: 
RiboRuler RNA ladder, high range; lane 2: RNA-TRI, before 
DNase digestion; lane 3: RNA-easy, before DNase digestion; lane 
4: RNA-TRI, after DNase digestion; lane 5: RNA-easy, after DNase 
digestion. The concentration is clearly higher in RNA samples 
obtained with TRIzol-chloroform-extraction. Small RNA fragments 
<200 bp are less abundant after RNeasy Kit RNA isolation. 
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D.3. Aminoallyl labeling 
 
One of the crucial steps in microarray analysis is the labeling of the RNA to turn it into a 
suitable target for hybridization. For this purpose, a reverse transcriptase enzyme is used to 
produce cDNA from RNA templates while incorporating aminoallyl dUTP nucleotides, the 
aminoallyl groups of which are then used to couple a fluorescent dye to the cDNA (section 
C.9.). In the start-up phase of the microarray, the CyScribe Post Labeling Kit had been 
successfully used for labeling until it stopped working suddenly without explainable reasons 
(Haider, unpublished). The procedure was subsequently changed to another labeling method 
(section C.9.) that was selected due to superior performance in a comparison of three different 
aminoallyl labeling protocols. 
 
Initial labelings that were used to establish the new protocol were carried out using the 
preliminary nucleotide mix (section C.9.1., Table 8) and are shown in detail in Table S4. In 
this first labeling series, the protocol yielded an average of 2.1 µg of fluorescently labeled 
cDNA per 20 µg of total RNA. The incorporated amount of CyDye per labeling was on 
average 445 pmol, resulting in an incorporation rate (FOI, frequency of incorporation) of 54 
for Cy5 and 69 for Cy3. Initial labelings with 5 µg enriched bacterial RNA as a templates 
yielded an average of 1.7 µg of labeled cDNA per 5 µg template and showed lower FOIs for 
Cy5 ( x = 34) and comparable FOIs for Cy3 ( x = 62). 
 
The purification columns that were used to purify the labeling product have a maximum 
capacity of 10 µg, the amount of cDNA to be purified from a single labeling, however, is 
slightly higher. To avoid exceeding the maximum capacity of the purification columns, one 
Figure 5. RNA before and after enrichment with 
MICROBEnrich. Lane 1: RiboRuler RNA ladder, high 
range; lane 6: total RNA; lane 8: enriched bacterial 
RNA. Note that after the enrichment only the ribosomal 
RNA bands that run lower on the gel are visible, 
indicating that the larger eukaryotic rRNAs were 
successfully removed from the mixture. 
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labeling reaction was split to two columns for purification. This measure increased the 
efficiency of the labeling procedure that now yielded an average of 3.2 µg of labeled cDNA 
per 20 µg of input total RNA, an increase of 52%. Detailed results of the second labeling 
series using the preliminary nucleotide mix are shown in Table S5. An average of 620 pmol 
CyDye was incorporated, resulting in an average FOI of 63, whereas the FOI for Cy3 ( x = 
70) was slightly higher than for Cy5 ( x = 60) (Table S5). When bacterial RNA enrichment 
was performed, 5 µg of template RNA produced comparatively higher amounts of labeled 
cDNA (Table S5).  
 
It is generally recommended to use FOI values between 20 and 50  for successful microarray 
hybridizations, since lower FOI values will generate weak signals from poor incorporation, 
whereas a higher FOI might lead to quenching between the fluorophores (GE Healthcare 
2008). Since the FOI values of the initial hybridizations were located outside this area, the 
nucleotide mix used for reverse transcription was adjusted in order to achieve FOI values of 
35 in order to tolerate some variation in both directions. Different ratios of dTTP and aa-
dUTP in the nucleotide mix were tested and detailed results are supplied in Table S6. The 
preliminary nucleotide mix contained dTTP and aa-dUTP in a ratio of 1:6.25. In order to 
decrease the FOI, the amount of aa-dUTP was decreased. A dTTP:aa-dUTP ratio of 1:2 
produced average FOI values of 60, at a ratio of 1:1 the FOI decreased to 34, at 2:1 to 29.  
 
For further hybridizations a nucleotide mix with a dTTP:aa-dUTP ratio of 1:1 (6mM 
dATP/dCTP/dGTP, 3mM dTTP, 3mM aa-dUTP) was used. Labelings with this nucleotide 
mix performed reasonably well for Cy5, where the FOI values were stable between 22 and 41. 
Labelings using Cy3, in contrast, subsequently showed higher FOIs (up to an FOI of 57) with 
the 1:1-nucleotide mix, and further optimization of a separate nucleotide mix for labeling with 
Cy3 was carried out (Table S7). The 4:3-nucleotide mix worked best (average FOI of 41), 
2:1- and 3:2-nucleotide mixes lead to FOIs that were slightly too low (average FOIs of 26 and 
28, respectively). 
 
Nevertheless, labelings using the Cy3 fluorophore did not perform as well as Cy5-labelings, 
the background after hybridizations was always considerably higher, thus reducing the signal-
to-noise ratios. For this reason and since the hybridization of genomic DNA labeled in Cy3 
was working, further cDNA labelings were conducted with Cy5, while Cy3-labeled genomic 
DNA was used for normalization. The aminoallyl labeling with Cy5 subsequently produced 
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stable results (Table S8) with incorporation ratios between 22 and 41 ( x = 33). One labeling 
reaction (20 µg template RNA) produced an average amount of 3.2 µg labeled cDNA with 
336 pmol of incorporated Cy5. 
 
 
D.4. cDNA amplification and direct labeling 
 
D.4.1. cDNA amplification 
The bacterial RNA enrichment using MICROBEnrich did not lead to improved hybridization 
results (section D.7.3.). In order to enhance the performance of enriched samples, an 
amplification step was introduced before the fluorescent labeling of cDNA (section C.10.). 
The enriched RNA was reversely transcribed and amplification was performed using the 
illustra GenomiPhi V2 DNA Amplification Kit, thereby producing a large amount of DNA of 
high molecular weight from a very small amount of cDNA (Figure 6). The kit provided stable 
amplification independent of the amount of template cDNA that varied between 50 ng and 1 
µg with an average amplification yield of 16.6 µg of DNA. However, the quantitation of 
unpurified amplification products using Nanodrop is inaccurate due to presence of protein and 
other kit components (GE Healthcare 2003) and presumably the amount of DNA is seriously 
overestimated. 
 
  
 
D.4.2. Restriction enzyme digestion of amplified cDNA 
The GenomiPhi Kit produces DNA of high molecular weight not suitable for microarray 
hybridization. Therefore the amplification product was digested with the restriction enzyme 
Figure 6. cDNA amplification using GenomiPhi DNA 
Amplification Kit. A very small amount of enriched cDNA 
(lane 2) produces large amounts of DNA of high molecular 
weight (lane 3 and 4). Lane 1: GeneRuler 1kb. 
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BsuRI (Figure 7). BsuRI is a 4 base pair cutter that generates fragments of an average length 
of 256 base pairs by cutting at the recognition sequence 5’GG^CC-3’. The fact that most 
fragments visible in Figure 7 are much larger may be attributed to insufficient incubation 
time. 
 
D.4.3. Purification of amplified cDNA 
Before labeling, the amplified cDNA was purified using the QIAquick Nucleotide Removal 
Kit in order to remove all the components of the amplification and the restriction enzyme 
digestion. This lead to a great reduction in the amount of DNA that was measured (an average 
of 2.1 µg of purified DNA remained for an average of 16.6 µg of unpurified amplified DNA), 
partly due to actual loss during the purification procedure (Figure 7) and partly due to 
NanoDrop measurement overestimating the amount of DNA after amplification. 
 
 
 
D.4.4. Direct labeling of amplified cDNA 
For labeling of the amplified cDNA a protocol for labeling of genomic DNA was used 
(section C.12.). After purification, labelings of amplified cDNA showed results similar to 
genomic DNA labelings, without purification the labeling procedure was less efficient (Table 
S9). 
 
 
D.5. Hybridization with poly-dTTP spacer probes 
 
Poly-dTTP spacer probes (12 nucleotides) targeting the A-spacer of printed oligonucleotides 
were used to assess the spotting quality. Every first slide of a spotting series was subjected to 
a poly-dTTP hybridization and if not all spots were present the target height of the spotting 
Figure 7. Restriction digestion of amplified cDNA. 
Lane 1: GeneRuler 1kb; lane 2: amplified control 
DNA (Lambda, 10 ng/µL); lane 3: amplified cDNA; 
lane 7: restricted amplified control DNA; lane 8: 
restricted amplified cDNA; lane 12: purified restricted 
amplified control DNA; lane 13: purified restricted 
amplified cDNA. 
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pins was adjusted. The microarray consists of three replicated blocks (Figure 8A), each block, 
composed of 16 subgrids, contains probes targeting all 2,031 putative open reading frames of 
P. amoebophila, as well as a probe for the folA gene encoding dihydrofolate reductase (a gene 
found on a contig of P. amoebophila which could not be correctly assembled so far) and 
several positive and negative controls (Figure 8B). The four probes used as negative controls 
are derived from phylogenetically unrelated bacteria Desulfotomaculum thermoacetoxidans 
DSM 5813 (Firmicutes), Thermodesulfovibrio islandicus DSM 12570 (Nitrospira), 
Desulfovibrio profundus DSM 11384 (Deltaproteobacteria) and Thermodesulfobacterium 
thermophilum DSM 1276 (Thermodesulfobacteria) and do not show cross-hybridization to 
sample RNA. 
 
Figure 8. The P. amoebophila microarray after hybridization with a poly-dTTP spacer 
probe. (A) The microarray consists of three replicated blocks (B) A single block, composed 
of 16 subgrids, contains probes targeting all 2,032 annotated genes of P. amoebophila as well 
as several positive and negative controls. Negative controls are highlighted by white squares. 
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Since this poly-dTTP hybridization provides a cheap and easy means to conduct 
hybridizations that are at least to some degree comparable to cDNA hybridizations, it was also 
used to evaluate modifications to post-processing of the microarray slides and hybridization 
conditions. 
 
When problems with the reproduction of successful hybridizations were experienced (section 
D.7.5.), poly-dTTP hybridizations were performed to determine the reason for the poor 
reproducibility. A slide subjected to the standard hybridization procedure was compared to a 
slide from the same spotting series (spotting series #2110) but with all the chemicals and 
solutions replaced by new ones and to a slide from an older spotting series (spotting series 
#0807) (Table 13). No significant improvement could be observed when the chemicals were 
replaced, but the signal-to-noise ratio was remarkably higher when a slide from an older 
spotting series was used due to strongly increased signal intensities above a comparable 
background. 
 
Table 13. Poly-dTTP hybridization comparing replacement of slides and chemicals 
Hybridization Mean signal intensity values 
Mean background 
intensity values 
Mean signal-to-
noise ratio 
 Spotting series #2110 449 303 2 
 Spotting series #2110, new chemicals 473 277 3 
 Spotting series #0807 1464 280 19 
 
From then on, all the new spotting series were compared via a poly-dTTP hybridization to 
spotting series #2110 that served as a kind of negative control considered not suitable for 
hybridization (Table 14). Figure 9 shows relative signal-to-noise ratios standardized to 
spotting series #2110. Series #0711 had a signal-to-noise ratio that was clearly superior to 
#2110. Unfortunately, all subsequent spotting series (#2411, #2811, #0212) were comparable 
to spotting series #2110. The results of the simple hybridizations with poly-dTTP probes are 
consistent with the performances of the respective spotting series in cDNA hybridizations (see 
section D.7.). 
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Table 14. Comparison of new spotting series to spotting series #2110.  
Comparison* Mean signal intensity values 
Mean background 
intensity values 
Mean signal-to-
noise ratio 
        
 spotting series #2110 11111 91 1278 
 spotting series #0711 35982 164 2672 
 
      
 spotting series #2110 4958 35 1987 
 spotting series #2411 13725 93 1492 
  
      
 spotting series #2110 16472 70 2153 
 spotting series #2811 26549 123 2322 
  
      
 spotting series #2110 3557 32 1624 
 spotting series #0212 3906 40 1438 
*only slides from the same hybridization are comparable due to large variation in signal 
intensity between different hybridizations 
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Figure 9. Signal-to-noise ratios relative to spotting series #2110.   
 
It is hard to come up with a good explanation for the varying quality of the different spotting 
series, but it was suspected from observation, that longer reduction times in sodium 
borohydride might not only reduce the background intensities by inactivation of the slide 
surface, but also have a detrimental effect on the signal intensities, thereby decreasing the 
signal-to-noise ratio. Therefore, a test using poly-dTTP spacer probes and different lengths of 
reduction in sodium borohydride was performed (Figure 10). 
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Figure 10. Comparison of different times of exposure to sodium borohydride.  
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D.6. Hybridization with genomic DNA 
 
To adjust for effects which arise from variation in the microarray technology rather than from 
biological differences and to obtain quantitative results it is necessary to normalize the data. 
Normalization in cDNA microarray experiments can be conducted using genomic DNA. The 
number of detected genes was always ≥99%, when 1 or 2 µg of fragmented and labeled 
genomic DNA was hybridized to the microarray (Figure 11). When less genomic DNA was 
used, the number of genes detected was decreasing (97% - 0.5 µg, 77% - 0.25 µg). The 
negative controls were always below the signal threshold. 
 
A            B 
   
 
Figure 11. Hybridization with genomic DNA. White squares indicate negative controls. (A) 
Detail of subgrid 1 shows high intensities for all the spots except the negative controls with 
low background fluorescence. (B) Detail of block 1. 
 
 
  D. Results 
 51 
D.7. Hybridization with cDNA 
 
Hybridization was evaluated by calculating the mean SNR of the triplicates for every spot. 
When the mean SNR was >3 the spot was considered to give a signal. A mean of 61% of 
predicted genes in the P. amoebophila genome were found to be transcribed during infection 
(Haider, unpublished). For this reason, detection of around 60% of the genes was set as a 
target for the optimization process. Figure 13 shows an overview over the optimization 
process. 
 
 
 
Figure 13. Overview of the hybridization optimization process.  
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D.7.1. Initial hybridizations 
Initially, one labeling reaction with 20 µg of template RNA was used for one hybridization. 
Hybridization signals were generally very weak and the background intensities were relatively 
high so that only between 5% and 11% ( x = 9%) of the spots could be detected (Table 15). 
Following image (Figure 13) shows representative details of a hybridization of the first series. 
In that hybridization 11% of the spots had an SNR greater than 3 and were thus qualified as 
signals.  
 
Table 15. Hybridizations with initial labelings 
Labeling parameters Slide Initial amount 
of RNA CyDye cDNA (µg) CyDye (pmol) FOI 
Signals 
detected 
#2503-12 20 µg Cy5 1.2 194 55 5% 
#2503-13 20 µg Cy5 1.7 290 56 11% 
#2503-14 20 µg Cy5 1.6 188 58 9% 
#2503-15 20 µg Cy5 1.4 249 57 11% 
 
A              B 
 
Figure 13. Hybridization of Cy5-labeled cDNA on slide #2503-13 (A) Detail of subgrid 1 
illustrates the background fluorescence that is relatively high compared to the fluorescence 
intensity of the signals. Under such circumstances only the spots with the highest intensities 
are able to cross the detection threshold and many genes go undetected. (B) Detail of block 1 
shows the hybridization pattern of the chip. 
 
D.7.2. Commercially available hybridization buffers 
Two commercially available hybridization buffers were tested: Sigma’s PerfectHyb 
Hybridization Buffer and Ambion’s SlideHyb Glass Array Hybridization Buffer #1. Both 
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buffers produced very high signal intensities at the expense of specificity, since most of the 
negative controls showed signals. Attempts at increasing the specificity by increasing the 
stringency were not successful, but lead only to an overall decrease in signal intensity without 
restoring specificity. In the case of PerfectHyb Hybridization Buffer an additional problem 
was that the hybridization pattern of the microarray chip was completely different from the 
pattern observed in all the previous hybridizations with RNA from asynchronous cultures and 
was thought to not accurately represent the gene expression. Details of hybridizations using 
PerfectHyb and SlideHyb buffers are shown in Figure 14 and Figure 15, respectively. 
 
A          B 
    
 
Figure 14: Hybridization using PerfectHyb Hybridization Buffer on slide #2304-02. 
Negative controls are indicated by white squares. (A) Detail of subgrid 1. The signal intensity 
is very high and so is the signal to noise ratio, as the intensity of the background is relatively 
low. 70% of the spots produced signals. The hybridization, however, is completely unspecific 
and seems to occur on almost every spot, even on the negative controls that are curiously 
among the most intense signals observed. (B) Detail of block 1 shows the completely altered 
hybridization pattern of hybridizations using PerfectHyb Hybridization Buffer. 
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A             B 
    
 
Figure 15. Hybridization using SlideHyb Glass Array Hybridization Buffer #1 on slide 
#2304-16. Negative controls are indicated by white squares. (A) Detail of subgrid 1. Signal 
intensities are comparably high but signal-to-noise ratios are lower when using SlideHyb than 
when using PerfectHyb due to higher background. (B) Detail of block 1. Using SlideHyb the 
microarray once again shows its familiar hybridization pattern. 
 
D.7.3. Hybridization after bacterial RNA enrichment 
Hybridization after bacterial RNA enrichment could not improve the signal intensities (Table 
16). Hybridizations with labelings of 5 µg of enriched RNA as template produced results 
similar to hybridizations with labelings of 20 µg of total RNA as template: slides #2503-16 
and #2503-17 were hybridized with initial labelings using the preliminary nucleotide mix and 
can be directly compared to the respective hybridizations from total RNA (section 7.1., Table 
15). When more RNA was used as a template for bacterial RNA enrichment and therefore 
more cDNA was used for hybridization, the percentage of detected signals increased (slide 
#0807-12). Curiously, when two labelings from 5 µg of enriched cDNA were pooled and 
used, the hybridization showed positive negative controls (slide #0807-11). 
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Table 16. Hybridizations after bacterial RNA enrichment 
Labeling parameters Slide Initial amount 
of RNA CyDye cDNA (µg) CyDye (pmol) FOI 
Signals 
detected 
#2503-16 5 µg Cy5 0.9 180 67 9% 
#2503-17 5 µg Cy5 1.8 245 41 11% 
#0807-11 10 µg Cy5 3.9 746 62 65%* 
#0807-12 16 µg Cy5 2.7 593 72 22% 
* unspecific binding 
 
D.7.4. Optimization of cDNA amount used in hybridization 
Since neither the application of the commercially available hybridization buffers nor the 
bacterial RNA enrichment could improve the hybridization, it was tried to optimize the 
standard labeling procedure (section D.3.). Avoiding the overloading of the purification 
columns lead to an increased labeling efficiency that was also reflected in the performance of 
the hybridizations, the number of signals detected could be raised to 22% (Table 17). 
 
Table 17. Hybridization with labeling reaction that was split for purification 
Labeling parameters Slide Initial amount 
of RNA CyDye cDNA (µg) CyDye (pmol) FOI 
Signals 
detected 
#0807-03 20 µg Cy3 3.0 758 79 22% 
 
After that, experiments were done to determine the optimal amount of cDNA to be hybridized 
(Table 18). The percentage of detected signals could be improved from 24% to 41% by 
increasing the amount of cDNA used for hybridization from 2.8 µg to 6.4 µg. If the amount of 
DNA was increased further to 8 µg of labeled cDNA, the percentage of detected signals 
dropped to 15%, possibly due to quenching effects or steric hindrance of DNA molecules. 
 
Table 18. Optimization of cDNA amount used in hybridization 
Labeling parameters Slide Initial amount 
of RNA CyDye cDNA (µg) CyDye (pmol) FOI 
Signals 
detected 
#0807-08 20 µg Cy5 2.8 461 53 24% 
#0807-09 30 µg Cy5 4.6 850 60 33% 
#0807-10 40 µg Cy5 6.4 1200 61 41% 
#0807-11 60 µg Cy3 8.0 1640 67 15% 
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D.7.5. Optimization of cDNA hybridization by adjusting the incorporation rates 
Another major step forward was the optimization of the nucleotide mix used for reverse 
transcription as described before (section D.3.). Up to that time a nucleotide mix was used 
that employed dTTP and aa-dUTP in a ratio of 1:6.25, which lead to an average FOI of 63. 
Adjusting this ratio to 1:1, an optimal average FOI of 33 was obtained. Table 19 shows 
hybridizations that were conducted during and after the optimization of the dTTP:aa-dUTP 
ratio. 
 
In the beginning, a labeling using the 1:2-nucleotide mix (FOI 34) was compared to a labeling 
that used the preliminary nucleotide mix with a 1:6.25 ratio (FOI 62) and the labelings were 
hybridized to slide #1908-02 and #1908-04, respectively, so that in both hybridizations 
approximately the same amount of CyDye was present. Although the amount of cDNA was 
therefore considerably lower for the hybridization with the 1:2 ratio, the percentage of 
detected signals was considerably higher (47% versus 21%). The next labelings with the 1:2-
nucleotide mix produced higher FOIs that performed accordingly in hybridization, the 
labeling with an FOI of 74 detected only 8% of the genes (slide #1908-05), the labeling with 
an FOI of 58 detected at least 34% (slide #1908-06). Consequently the amount of aa-dUTP in 
the nucleotide mix was further decreased to a dTTP:aa-dUTP ratio of 1:1 and even 2:1, that 
were used to produce labeled cDNA with FOIs of 34 and 28, respectively. When hybridized, 
the respective samples could only detect 26% (slide #1908-07) and 21% (slide #1908-08), but 
at least the FOI achieved with the 1:1-nucleotide mix seemed to be suitable. The following 
Cy3 labelings (slides #1908-09 to 13) further supported the superiority of the 1:1-nucleotide 
mix concerning the FOI, but satisfying hybridization results were not obtained until the first 
hybridization with Cy5 labeled cDNA (#1908-14). On this slide, to which the pooled products 
of two labeling reactions, containing 5.9 µg of cDNA and 635 pmol of Cy5, with an optimal 
FOI of 35 were hybridized, 62% of the genes could be detected (Figure 16). Reproducing this 
result was not easy, because labelings with similar amounts of cDNA and incorporated Cy5 
produced varying hybridization results by detecting 48% (slide #1908-17), 59% (slide #0807-
15), 25% (slide #0807-16), 26% (slide #2110-02), 44% (slide #2110-03), 27% (slide #2110-
04), 60% (slide #0711-01), and 55% (slide #0711-03). The reasons for the lacking stability of 
the hybridization results are not known, although it is suspected that the varying quality of 
different spotting series has a major impact on the hybridizations, as for example the 
hybridizations using slides from the #2110 series were considerably worse and this series was 
also shown to perform inferiorly in test hybridizations using poly-dTTP spacer probes 
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(section D.5.). Further labelings with Cy3 produced considerably lower signals, even after 
further optimization of the nucleotide mix it was not possible to obtain more than 43% 
signals. The four hybridizations that were considered successful and detected a sufficient 
number of genes ( x =59%) are shown in bold letters in Table 19. 
 
Table 19. Optimization of cDNA hybridization 
Labeling parameters Slide Initial amount 
of RNA CyDye 
dTTP:aa-
dUTP ratio cDNA (µg) CyDye (pmol) FOI 
Signals 
detected 
#1908-02 20 µg Cy3 1:2 4.0 416 34 47% 
#1908-04 17 µg Cy5 1:6.26 2.2 410 62 21% 
#1908-05 20 µg Cy3 1:2 4.1 932 74 8% 
#1908-06 20 µg Cy3 1:2 2.5 448 58 34% 
#1908-07 20 µg Cy3 1:1 2.4 252 34 26% 
#1908-08 20 µg Cy3 2:1 1.9 168 28 21% 
#1908-09 15 µg Cy3 1:2 3.2 624 61 8% 
#1908-10 20 µg Cy3 1:1 3.2 420 43 9% 
#1908-11 40 µg Cy3 1:1 5.2 632 40 43% 
#1908-12 30 µg Cy3 1:2 6.5 1308 65 35% 
#1908-13 40 µg Cy3 1:1 6.5 864 64 36% 
#1908-14 40 µg Cy5 1:1 5.9 636 35 62% 
#1908-15 15 µg Cy3 1:1 3.4 518 50 24% 
#1908-16 25 µg Cy3 1:1 6.4 966 49 34% 
#1908-17 40 µg Cy5 1:1 7.6 804 34 48% 
#1908-19 33 µg Cy5 1:1 4.7 354 24 32% 
#0807-15 53 µg Cy5 1:1 6.0 641 35 59% 
#0807-16 37 µg Cy5 1:1 5.9 658 37 25% 
#0807-17 40 µg Cy3 1:1 5.9 832 47 22% 
#0807-18 40 µg Cy3 1:1 5.6 820 47 23% 
#2110-02 40 µg Cy5 1:1 6.2 669 35 26% 
#2110-03 40 µg Cy5 1:1 6.8 770 37 44% 
#2110-04 40 µg Cy5 1:1 5.0 499 33 27% 
#0711-01 20 µg Cy5 1:1 6.4 648 33 60% 
#0711-03 30 µg Cy5 1:1 6.4 751 38 55% 
#0711-18 40 µg Cy3 3:2 7.5 656 28 23% 
#0711-19 40 µg Cy3 4:3 6.2 704 37 20% 
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A             B 
 
 
Figure 16. Hybridization of Cy5-labeled cDNA on slide #1908-14. (A) Detail of subgrid 1 
illustrates the high signal-to-noise ratio generated by high signal intensities and low 
background fluorescence. Most spots visible on the picture are above the signal threshold. (B) 
Detail of block 1. Altogether, 62% of the genes are detected. 
 
D.7.6. Normalization with genomic DNA 
The next step was to normalize the cDNA hybridization by co-hybridization with genomic 
DNA. Unfortunately, the good performance of the cDNA hybridization could not be 
reproduced when hybridized in combination with genomic DNA (Table 20). While genomic 
DNA hybridization always detected ≥99% of the genes, the percentage of signals detected 
from cDNA was never above 26% (Figure 17). In the first two attempts to normalize the 
cDNA hybridization of an asynchronous culture with genomic DNA only 25% and 24% of 
the genes could be detected. To determine whether the co-hybridization of gDNA was 
responsible for the low hybridization signals or it was an independent problem, two duplicate 
hybridizations were performed, one of them with addition of 1 or 2 µg of gDNA and one 
without addition of gDNA. The normalized hybridization did always detect less genes than 
the hybridization without gDNA addition (21% versus 23%, 13% versus 18%), an effect that 
was even more pronounced when the CyDyes were switched (12% versus 25%), but this 
reduction was not responsible for the comparably poor performance of these hybridizations. 
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Table 20. Normalization with genomic DNA 
Labeling parameters Slide Initial amount of RNA cDNA (µg) Cy5 (pmol) FOI Cy3-gDNA 
Signals 
detected 
#0711-12 25 µg 5.5 644 38 1 µg 25% 
#0711-13 27 µg 6.1 614 31 1 µg 24% 
#0711-14 40 µg 4.8 422 29 - 23% 
#0711-15 40 µg 4.8 422 29 1 µg 21% 
#0711-16 20 µg 3.9 512 (Cy3) 43 - 25% 
#0711-17 20 µg 3.7 476 (Cy3) 42 1 µg (Cy5) 12% 
#2411-02 40 µg 9.2 758 27 - - 
#2411-03 40 µg 9.2 758 27 1 µg 26% 
#0212-02 27 µg 6.6 659 32 - 18% 
#0212-03 27 µg 6.6 659 32 2 µg 13% 
 
A          B 
    
 
Figure 17. Co-hybridization of cDNA (Cy5, red) and genomic DNA (Cy3, green) on slide 
#2411-03. Only about a quarter of the spots (26%) are detected by both samples and therefore 
appear yellow. (A) Detail of subgrid 1. (B) Detail of block 1. 
 
D.7.7. Hybridization of amplified cDNA  
In order to enhance signal intensity, the DNA amplification method GenomiPhi was tested. 
But hybridizations of cDNA that was amplified with the GenomiPhi kit and directly labeled 
using a Klenow fragment based labeling protocol did not fulfill the expectations. 7 out of 8 
hybridizations with labeled amplified cDNA did not produce any hybridization signals at all 
(Table 21). The single hybridization signal that did show hybridization (slide #2811-15) 
obtained 24% signals, no unspecific binding to negative controls, but a hybridization pattern 
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that was different from the conventional cDNA hybridizations. Besides, hybridization of 
genomic DNA after amplification showed unspecific binding in one of out of two runs. 
 
Table 21. Hybridization with amplified and directly labeled cDNA  
Slide Template RNA enrichment 
Reverse 
transcription 
cDNA 
amplification 
Restriction 
digestion Purification 
Signals 
detected 
#2811-04 DD18       0% 
#2811-05 DD18        0% 
#2811-12 DD18       0% 
#2811-14 DD18       0% 
#2811-15 RNA-TRI      24% 
#2811-16 RNA-TRI      0% 
#2811-17 RNA-easy      0% 
#2811-18 RNA-easy      0% 
#2811-19 gDNA        99% 
#2811-20 gDNA        99% 
 
 
A           B 
    
 
Figure 18. Hybridization of amplified cDNA on slide #2811-15. Most signals are below the 
threshold and the hybridization pattern is altered (compare to Figures 12 and 15). (A) Detail 
of subgrid 1. (B) Detail of block 1. 
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D.8. Amoeba isolation 
 
D.8.1. Extraction of amoebae on non-nutrient agar 
The objective of the experiment was the isolation of amoebae from environmental samples 
and to culture them under axenic conditions. For this purpose, two different samples were 
taken in Feldkirch (Vorarlberg), soil from a molehill in a garden (sample A) and sediment 
from the shores of a quarry lake (sample B). Three replicate extractions were performed for 
each sample (samples AAI-1 to 3 and BAI-1 to 3). Table 22 shows the six amoeba isolates 
and the respective outcome of the extraction. 
 
Table 22. Extraction of amoebae on non-nutrient agar 
Sample Amoeba isolate  Result of extraction 
AAI-1  No axenic growth in liquid media 
AAI-2  No growth on NNA plates with dead E. coli Sample A 
AAI-3  No growth on NNA plates with dead E. coli 
BAI-1  Axenic culture could be established 
BAI-2  No growth on NNA plates with dead E. coli Sample B 
BAI-3  No attachment to the surface of the culture flasks 
 
After the samples were placed on NNA plates seeded with living E. coli, amoebae were 
feeding on the bacteria and multiplying, thereby moving out of the sample. Amoebae could be 
transferred to new NNA plates seeded with living E. coli by cutting out small pieces of agar 
from the edges of the plates. The transfer of fast growing contaminations, especially fungi, 
could be successfully avoided. After five rounds of transfer, the living E. coli cells were 
replaced with heat-inactivated E. coli cells to cautiously prepare them for axenization. The 
dead cells, however, were not readily accepted as a food source, and amoebal growth was 
either substantially slowing down or stopped altogether. Three of the six amoeba isolates did 
not grow at all on heat-inactivated E. coli, namely isolates AAI-2, AAI-3 and BAI-2. From 
the other three extractions, three different types of amoebae could be separated on non-
nutrient agar plates and were subsequently transferred to cell culture flasks. 
 
When examined under the light microscope, two of them phenotypically resembled 
Acanthamoeba species (AAI-1 and BAI-1) while the third (BAI-3) was phenotypically similar 
to Naegleria species. All three survived the hydrochloric acid treatment and excysted when 
incubated in PYG. Isolate AAI-1, however, did not grow at all neither in PYG nor in Chang 
medium and the culture was eventually discarded. The Naegleria-like BAI-3 cells did grow 
well at first, but only when supplied with heat-inactivated bacterial cells as a food source. 
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However, after a few days the cultures were lost as the medium was replaced since the 
amoebae failed to attach to the surface of the culture flasks. BAI-1 cells grew very slowly in 
PYG and Chang medium, but showed fast growth in PYNFH medium and could be 
established as axenic culture. 
 
D.8.2. Fluorescence in situ hybridization 
Fluorescence in situ hybridization (FISH) is a method of cultivation independent 
identification of bacteria using fluorescently labeled oligonucleotide probes and therefore it is 
particularly suited for detecting the presence of uncultivable intracellular endosymbionts 
within acanthamoebae.  
 
DAPI-staining (section C.20.3.) of the amoeba isolate BAI-1 could show the presence of 
intracellular coccoid bacteria (data not shown). For identification, the isolated amoebae were 
subjected to FISH analysis. A Chlamydiales-specific probe (Chls-0523) was used 
simultaneously with a universal probe targeting most bacteria (EUB338). The bacterial probe 
generated multiple signals in most amoebal cells (Figure 19), confirming the presence of 
intracellular bacteria within the isolated amoebae already detected by DAPI-staining. All of 
these signals matched with the signals obtained with the Chlamydiales-specific probe (Figure 
19), indicating that all the symbionts belong to the order Chlamydiales. No signals were 
obtained using the nonsense probe NONEUB, the Betaproteobacteria-specific probe BET42a, 
and the Alphaproteobacteria-specific probe ALF968. 
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Figure 19. Fluorescence in situ hybridization using universal bacterial probe EUB338 
(FLUOS, green) and Chlamydiales-specific probe Chls-0523 (Cy3, red). Signals of both 
probes match in an overlay. Differential interference contrast (DIC) is shown for better 
overview. (A) Detail showing one amoeba cell. Bar indicates 10 µm. (B) Larger detail 
showing several amoebae. Bar indicates 20 µm. CLSM pictures by K. Aistleitner. 
 
D.8.3. Identification of isolated amoebae and their symbionts 
For further characterization of the isolate BAI-1, DNA was isolated from the amoebae and 
their intracellular symbionts. Using primers suitable for amplification of the 18S rRNA gene 
of acanthamoebae, a 2197 nucleotide long sequence of the 18S rRNA gene was obtained and 
BLAST analysis (Altschul et al. 1990) confirmed their affiliation to the genus Acanthamoeba 
as assumed from phenotypical appearance. The 18S rRNA sequence displayed 100% identity 
(100% query coverage) to Acanthamoeba castellanii Neff ATCC 50373 18S rRNA gene 
sequence. Figure 20 shows the position of amoeba isolate BAI-1 in a phylogenetic tree and its 
affiliation to sequence type 4 (T4). 
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Figure 20. Phylogenetic affiliation of amoeba isolate BAI-1 based on 18S rRNA sequence 
analysis. Tree calculation was performed using the neighbour joining algorithm (jukes cantor 
distance correction) in ARB (Ludwig et al. 2004), scale bar represents 10% estimated 
evolutionary distance. 
 
The 16S rRNA gene sequence of the intracellular symbiont BAI-1 obtained with primers 
specific for the order Chlamydiales was 1378 nucleotides in length and showed highest 
similarities to following 16S rRNA sequences in the database (Table 23): 
 
Table 23. Most similar 16S rRNA sequences found by BLAST analysis 
 16S rRNA gene sequence Mismatches Max identity 
 Endosymbiont of Acanthamoeba sp. UWC22 4 99% 
 Endosymbiont of Acanthamoeba sp. TUME1 8 99% 
 Neochlamydia sp. CRIB37 13 99% 
 Neochlamydia hartmannellae 46 96% 
 
Phylogenetic analysis confirmed the similarity inferred affiliation of the BAI-1 symbiont 
(Figure 21). It belongs to the family Parachlamydiaceae and is closely affiliated with the 
genus Neochlamydia. 
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Figure 21. Phylogenetic affiliation of the BAI-1 endosymbiont based on 16S rRNA 
analysis. Tree calculation was performed using the neighbour joining algorithm (jukes cantor 
distance correction) in ARB (Ludwig et al. 2004), scale bar represents 10% estimated 
evolutionary distance. 
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E. Discussion 
 
E.1. Optimization of the P. amoebophila whole genome microarray 
 
E.1.1. Preconditions 
The availability of the complete genome sequence of the obligate intracellular symbiont P. 
amoebophila (Horn et al. 2004), a member of the environmental chlamydiae, provided the 
opportunity to design a whole genome microarray to explore its gene expression during 
intracellular growth and reveal new insights into the interaction with its host (Haider, 
unpublished). However, microarray analysis of obligate intracellular bacteria is technically 
challenging and the procedure was experiencing problems the precise nature of which was not 
entirely clear. One particular issue being the application of the commercially available two-
step random labeling kit CyScribe (Amersham Biosciences) that had to be replaced by another 
labeling method (section C.9.) due to a sudden breakdown in performance (Haider, 
unpublished). However, it was still not possible to detect a sufficient number of genes with 
the microarray. An estimated 61% of genes in the P. amoebophila genome were found to be 
transcribed during infection (Haider, unpublished), a number that is comparable to the 
proportion of transcribed genes reported for other bacterial species that range between 40% 
and 76% expressed genes (Talaat et al. 2002; Corbin et al. 2003; Guina et al. 2003; Wei et al. 
2006). For this reason, detection of around 60% of the genes was set as a target for the 
optimization process. Initially, however, the number of genes that could be detected was only 
9% (section D.7.1.). 
 
E.1.2. Application of commercially available hybridization buffers 
To solve this problem, two different commercially available hybridization buffers were 
obtained and tested, but without success (section D.7.2.). They both produced very high 
hybridization signals, but did so at the expense of specificity and it was not possible to obtain 
strong and specific hybridization signals by increasing the stringency during hybridization 
and washing. PerfectHyb Hybridization Buffer (Sigma) generated very high signal intensities, 
but some of the negative controls were among the strongest signals and the hybridization 
pattern was completely changed in comparison to all previous hybridizations. SlideHyb Glass 
Array Hybridization Buffer #1 (Ambion) preserved the usual hybridization pattern, but the 
signal intensities were lower compared to PerfectHyb hybridizations and unspecific binding 
occurred nevertheless.   
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E.1.3. Optimizing hybridization with aminoallyl labeled cDNA 
A major focus of this study was the optimization of the labeling method used to prepare the 
samples for hybridization. An indirect two-step labeling strategy (section C.9.) was employed 
to produce cDNA with incorporated aminoallyl-dUTPs to which a fluorescent dye was 
coupled in a second step. During optimization of the labeling procedure (section D.3.) it was 
found that the labeling efficiency was increased by using two purification columns for one 
labeling reaction in order not to exceed the maximum capacity. Progress in hybridization 
optimization could be made by increasing the amount of labeled cDNA that was used for 
hybridization, raising the number of genes that could be detected to 41% (section D.7.4.). 
More headway was made by adjusting the frequency of incorporation (FOI) of the fluorescent 
dye into the cDNA (D.7.5.). It is generally recommended to use FOI values between 20 and 
50 (incorporation of 20 to 50 labeled nucleotides per 1000 nucleotides of cDNA) for 
successful hybridizations, since lower or higher FOIs might generate weak signals upon 
hybridization due to poor incorporation and quenching effects between fluorophores, 
respectively (GE Healthcare 2008). The FOI can be adjusted by altering the composition of 
the nucleotide mix used for reverse transcription. The amount of aa-dUTP, to which the 
fluorescent dye is coupled after reverse transcription, in proportion to the amount of dTTP 
determines the dye incorporation. Using the preliminary nucleotide mix that contained dTTP 
and aa-dUTP in a ratio of 1:6.25, the FOIs were much higher than the recommended values. 
After a few experiments with different nucleotide mixes, the nucleotide mix containing equal 
concentrations of dTTP and aa-dUTP was found to give the best results with an average FOI 
of 33. With this nucleotide mix, good hybridization results with up to 62% detected signals 
could be obtained. However, the results were not easily reproducible and sometimes the 
hybridizations did not work for no obvious reason. One of the technical issues that seemed to 
be responsible for low signal-to-noise ratios in a number of hybridizations was the varying 
quality of the different slide spotting series that for some reason were not equally well suitable 
for hybridization (Tables 13 and 14, Figure 9). An influence of different reduction times in 
sodium borohydride was assumed, but could not be confirmed using poly-dTTP hybridization 
(Figure 10). 
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E.1.4. Normalization using genomic DNA 
Nevertheless, it was attempted to normalize the cDNA hybridizations in order to obtain 
quantitative transcriptional data about an asynchronous culture of P. amoebophila. The 
normalization procedure to be used was most similar to the genomic normalization procedure 
described in Talaat et al. 2002 and is based on the comparison of gene expression levels to 
signals generated from genomic DNA. Genomic DNA was found to be a reliable universal 
standard for gene expression measurements, since all genes are represented with constant 
copy number (Pollack et al. 1999; Talaat et al. 2002; Weil et al. 2002; Williams et al. 2004; 
Gadgil et al. 2005). Genomic DNA hybridization performed well, all the spots with the 
exception of the negative controls and occasional spotting failures gave signals above the 
threshold. The number of detected genes was always ≥99%. When hybridized simultaneously 
with Cy3-labeled genomic DNA, however, the Cy5-labeled cDNA never generated more than 
26% signals. Generally, the signals obtained with cDNA were approximately 2.5 times lower 
than signals obtained from genomic DNA hybridization, contradictory to a previous report 
stating that most RNA samples generate higher signals than genomic DNA samples due to the 
presence of multiple transcripts per gene (Talaat et al. 2002). The poor performance of the 
cDNA hybridization during normalization, however, could not be attributed to a detrimental 
effect of the additional genomic DNA, since only marginally more signals were generated in 
comparable cDNA only hybridizations. 
 
E.1.5. Bacterial RNA enrichment 
The good performance of the microarray when used with genomic DNA sharply contrasts to 
the problems that were experienced when cDNA samples were analyzed and indicates that the 
preparation of the RNA samples might be of fundamental importance. Actually, the extraction 
of adequate quantities of intact bacterial mRNA is considered to be the most important factor 
for a successful application of microarray technology (Mangan et al. 2002). In this study, 
asynchronous cultures of amoebae infected with P. amoebophila were used to isolate large 
quantities of a mixture of bacterial and amoebal RNA. The actual fraction of mRNA derived 
from the chlamydial endosymbiont, however, might still be present in concentrations too low 
for successful analysis and might be subject to fast degradation processes. Indeed, bacterial 
mRNA constitutes only a marginal proportion of the total RNA, since generally only 3% of 
the entire RNA content of a cell is mRNA, the rest being mainly rRNA and tRNAs (Alberts 
1994). Furthermore, in case of intracellular symbionts, the amount of eukaryotic host RNA by 
far exceeds the amount of bacterial RNA, as shown for Rickettsia prowazekii, where 
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rickettsial RNA makes up less than 10% of the total RNA extracted from rickettsia-infected 
host cells (Audia et al. 2008). By default, only total RNA can be labelled by random priming, 
because specific labeling of mRNA is not possible since bacterial mRNA lacks 
polyadenylation. This fact, however, can be taken advantage of by using the poly(A) tail that 
is characteristic for eukaryotic mRNA to selectively remove these sequences from a complex 
host-bacteria RNA mixture. The MICROBEnrich kit employs magnetic beads, derivatized 
with oligonucleotides that hybridize not only to the polyadenylated 3’ ends of eukaryotic 
mRNA but also to 18S and 28S rRNAs, and was used to enrich the total RNA samples 
extracted from infected amoebae in chlamydial RNA. Hybridization with enriched RNA, 
however, did not lead to an observable improvement of the hybridization. When raising the 
amount of enriched cDNA used for hybridization for some reason generated unspecific 
binding to the negative controls, the method was put aside until the application of a linear 
amplification technique promised a new way to benefit from bacterial RNA enrichment.  
 
E.1.6. cDNA amplification 
The GenomiPhi DNA Amplification Kit utilizes the bacteriophage Phi29 DNA polymerase to 
linearly amplify DNA templates during a strand displacement reaction that is highly accurate 
due to the polymerase’s proofreading activity (Lizardi et al. 1998; Dean et al. 2001). The kit 
had been tested for use in transcriptional microarray analyses of low abundance prokaryotic 
RNA sources and was found to provide linear amplification with equivalent results in terms of 
relative messenger abundance as those obtained by conventional direct reverse-transcription 
(Francois et al. 2007) and has already been used successfully in transcriptional gene 
expression analysis of intracellular bacteria (Garzoni et al. 2007; Renesto et al. 2008). In this 
study, the GenomiPhi DNA amplification Kit was applied without success (D.7.7.). 
Reasonable hybridization results – although in one case showing unspecific binding – were 
obtained with genomic DNA control amplifications but not when cDNA was used as a 
template. Only one out of eight hybridizations with amplified cDNA showed any 
hybridization signals at all and they were not particularly promising as only 24% of genes 
were detected and the hybridization pattern was altered to such a degree that the fact that the 
cDNA originated from a different RNA isolation experiment might be not sufficient to serve 
as an explanation (Figure 18). 
 
 
 
E. Discussion 
 70 
E.1.7. Conclusion 
In conclusion, progress could be made in the optimization of the microarray procedure and 
successful cDNA hybridizations were performed, in which 55% - 62% ( x =59%) of genes 
were found to be expressed during growth of P. amoebophila in asynchronous infection. 
Unfortunately, the procedure did not show stable performance, as results were often not 
readily reproducible and quantitation using genomic DNA for normalization was not 
successful. It is tempting to speculate that the achievement of quantitative normalized results 
is just a matter of time and effort and might soon be accomplished, but more energy has to be 
spent on optimizing the reproducibility and solving technical issues until the microarray can 
be used for more sophisticated expression profiling studies. 
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E.2. Amoeba isolation 
 
Another aim of this thesis was the isolation of amoebae from environmental samples and to 
test them for the presence of endosymbionts. Environmental samples were taken (section 
C.20.1.) and amoebae isolated from sediment of the shore of a quarry lake could successfully 
be established as an axenic culture (section D.8.1). Using DAPI-staining (section C.20.3.) a 
great amount of intracellular bacteria of coccoid shape could be detected within the amoebal 
cells, equally dispersed in the cytoplasm. Due to their coccoid morphology it was speculated 
that the symbionts might be chlamydiae, since an estimated 24% of Acanthamoeba species 
harbour bacterial endosymbionts, 20% gram negative rods and 5% gram negative cocci 
(Fritsche et al. 1993), and the latter were shown to belong to the order Chlamydiales (Fritsche 
et al. 2000). This hypothesis was supported by FISH analysis (section C.20.4.) that identified 
all intracellular bacteria as members of the order Chlamydiales by the use of general bacterial 
(EUB-338) and Chlamydiales-specific (Chls-0523) probes (section D.8.2.). To confirm these 
results and to phylogenetically classify both host amoebae and symbionts, sequences of the 
respective small subunit ribosomal RNA genes were obtained by DNA isolation, PCR 
amplification and direct sequencing (section D.8.3.). BLAST analysis could identify the host 
amoebae as Acanthamoeba castellanii since the 18S rRNA gene showed 100% sequence 
identity with the A. castellanii Neff ATCC 50373 strain. When the 16S rRNA gene sequence 
of the bacterial symbionts was compared to the sequences in the NCBI database, they showed 
a similarity of up to 99% to Neochlamydia-like symbionts of Acanthamoebae species (Table 
23). Furthermore, with the obtained sequences it was possible to use the ARB software to 
align the sequences with a database and calculate phylogenetic trees from these alignments. 
Unsurprisingly, the 18S rRNA sequence of the isolated amoebae clustered with A. castellanii 
Neff within the T4 sequence type of Acanthamoebae species (Figure 20). The T4 sequence 
type is by far the largest of the 12 Acanthamoeba lineages described so far (sequence types 
T1-T12) and contains six closely related nominal species, including almost all isolates from 
amoebic keratitis (Gast et al. 1996; Stothard et al. 1998). The 16S rRNA tree showed the 
affiliation of the BAI-1 symbiont with the family Parachlamydiaceae, more specifically with 
a branch comprising species of the genus Neochlamydia (Figure 21). The Parachlamydiaceae 
are the family of environmental chlamydiae represented by the highest number of identified 
organisms. It contains three genera, Parachlamydia, Neochlamydia, and Protochlamydia, 
members of which are almost always associated with free-living amoebae (Amann et al. 1997; 
Horn et al. 2000; Casson et al. 2008; Kuo et al. 2008). The most similar (99% sequence 
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identity) and most closely related sequences belong to endosymbionts of Acanthamoeba sp. 
UWC22 and TUME1 that were recovered from infected corneal tissue (UWC22) and 
municipal sewage sludge from Munich, Germany (TUME1) (Fritsche et al. 2000). The closest 
relative that has been thoroughly described as a species is Neochlamydia hartmannellae that 
was found living intracellularly in the amoeba Hartmannella vermiformis (Horn et al. 2000). 
Affiliation with the genus Neochlamydia is supported by the high sequence similarity (99%) 
to Neochlamydia sp. CRIB37, a strain isolated from a sediment sample of a drinking water 
treatment plant (Corsaro et al. 2009). The successful isolation of a Neochlamydia-like 
endosymbiont once again shows the ubiquitous distribution of environmental chlamydiae. 
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F. Summaries 
 
F.1. Summary 
 
Chlamydiae are obligate intracellular bacteria that share a unique biphasic developmental 
cycle (Ward 1988; Moulder 1991; Abdelrahman et al. 2005). They were long viewed as a 
phylogenetically well-separated group comprising a few closely related pathogenic species 
(Schachter 1999), until the recent discovery of a huge chlamydial diversity in the environment 
(reviewed in Horn 2008). The availability of the complete genome sequence of the 
environmental chlamydia Protochlamydia amoebophila UWE25 (Horn et al. 2004) provided 
the opportunity to design a whole genome microarray to explore its gene expression during 
intracellular growth and reveal new insights into the interaction with its host (Haider, 
unpublished). The aim of this study was the optimization of this whole-genome microarray 
and the establishment of a procedure suitable for studying the gene expression of P. 
amoebophila. It is shown that optimization of the aminoallyl labeling procedure lead to 
successful hybridization of P. amoebophila cDNA and detection of 59% expressed genes 
during asynchronous infection. Unfortunately, the hybridization results were not easily 
reproducible and quantitation of gene expression by normalization with genomic DNA was 
not possible. A recurring problem were low signal intensities upon hybridization. 
Sophisticated commercially available methods were employed to solve this issue, but without 
success. The total RNA samples were enriched in bacterial RNA by removal of eukaryotic 
host RNA using MICROBEnrich (Ambion), yet the enriched samples did not show an 
improved performance. In order to increase signal intensities, the linear amplification method 
GenomiPhi (GE Healthcare) was used for cDNA amplification, also without satisfactory 
results. In addition, the two commercially available hybridization solutions PerfectHyb 
(Sigma) and SlideHyb (Ambion) were unsuccessfully tested. In conclusion, progress could be 
made in optimization of the microarray procedure and successful cDNA hybridizations were 
performed, but more energy has to be spent on improving the reproducibility and solving 
technical issues until the microarray can be used for more sophisticated expression profiling 
studies. 
 
This study also reports on the successful isolation of the Neochlamydia-like symbiont BAI-1 
living intracellularly in an Acanthamoeba castellanii strain extracted from sediment from the 
shores of a quarry lake. 
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F.2. Zusammenfassung 
 
Chlamydien sind obligat intrazelluläre Bakterien, die sich durch einen einzigartigen zweiphasigen 
Entwicklungszyklus auszeichnen (Ward 1988; Moulder 1991; Abdelrahman et al. 2005). Lange 
Zeit wurden sie als phylogenetisch gut abgesonderte Gruppe betrachtet, bestehend aus einigen 
wenigen nah verwandten pathogenen Arten (Schachter 1999), bis zur kürzlichen Entdeckung einer 
enormen Diversität an Chlamydien in der Umwelt (zusammengefasst in Horn 2008). Die 
Verfügbarkeit einer kompletten Genomsequenz der Umweltchlamydie Protochlamydia 
amoebophila UWE25 (Horn et al. 2004) ermöglichte die Entwicklung eines globalen Microarrays, 
um die Genexpression von P. amoebophila während des intrazellulären Wachstums zu erforschen 
und neue Erkenntnisse über die Interaktionen mit ihrem Wirt zu erzielen (Haider, 
unveröffentlicht). Das Ziel dieser Diplomarbeit war die Optimierung dieses Microarrays und die 
Etablierung eines Verfahrens, das es erlaubt die Genexpression von P. amoebophila zu 
untersuchen. Es wird gezeigt, dass die Optimierung des Aminoallyl-Labeling-Protokolls zu 
erfolgreichen Hybridisierungen der P. amoebophila cDNA und zur Detektion von 59% 
exprimierten Genen während einer asynchronen Infektion führte. Unglücklicherweise waren die 
Hybridisierungsergebnisse nicht leicht zu reproduzieren und die Quantifizierung der 
Genexpression durch Normalisierung mit genomischer DNA war nicht möglich. Ein 
wiederkehrendes Problem waren niedrige Signalintensitäten bei der Hybridisierung. Um dieses 
Problem zu lösen, wurden neben den kommerziell erhältlichen Hybridisierungslösungen 
PerfectHyb (Sigma) und SlideHyb (Ambion) auch komplexe kommerziell erhältliche Methoden 
angewandt, allerdings ohne Erfolg. So wurde MICROBEnrich (Ambion) verwendet, um den 
Anteil an bakterieller RNA in den Gesamt-RNA-Proben durch Entfernung der eukaryotischen 
Wirts-RNA zu erhöhen, doch die Anreicherung hatte keinen positiven Effekt auf die nachfolgende 
Hybridisierung. Um die Signalintensitäten zu verstärken, wurde auch die lineare 
Amplifikationsmethode GenomiPhi (GE Healthcare) zur cDNA Amplifizierung getestet, jedoch 
ebenfalls ohne befriedigende Ergebnisse. Zusammenfassend wurden Fortschritte bei der 
Optimierung des verwendeten Verfahrens erzielt und erfolgreiche cDNA Hybridisierungen 
durchgeführt. Bis der Microarray für anspruchsvolle Genexpressionsstudien verwendet werden 
kann, sind jedoch neben der Lösung einiger technischer Probleme noch weitere Anstrengungen 
zur Verbesserung der Reproduzierbarkeit notwendig.  
 
Des Weiteren beschreibt diese Studie die erfolgreiche Isolierung des Neochlamydia-ähnlichen, 
intrazellulären Symbionten BAI-1 innerhalb eines Acanthamoeba castellanii Stammes, der aus 
dem Sediment vom Ufer eines Baggersees extrahiert wurde. 
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G. Appendix 
 
Supplementary tables: 
 
Table S1. Isolated RNA (before DNase digestion) 
Sample Concentration* Volume RNA amount Ratio 260/280 Ratio 260/230 
RNA 01 4509.5 ng/µL 50 µL 225 µg 1.60 1.31 
RNA 02 3657.4 ng/µL 50 µL 183 µg 1.96 1.08 
RNA 03 4579.4 ng/µL 50 µL 229 µg 1.53 1.34 
RNA 04 4627.2 ng/µL 50 µL 231 µg 1.40 1.20 
RNA 05 4624.4 ng/µL 50 µL 231 µg 1.31 1.24 
RNA 06 1955.6 ng/µL 50 µL 98 µg 2.06 0.92 
RNA 07 4603.3 ng/µL 50 µL 230 µg 1.41 1.23 
RNA 08 4717.6 ng/µL 50 µL 236 µg 1.34 1.24 
RNA 09 3880.9 ng/µL 50 µL 194 µg 1.81 1.06 
RNA 10 4162.0 ng/µL 50 µL 208 µg 1.92 1.39 
RNA 11 4773.0 ng/µL 50 µL 239 µg 1.05 1.17 
RNA 12 4706.4 ng/µL 50 µL 235 µg 1.31 1.16 
* Most values pass the detection limit of 3,700 ng/µL, the concentration measurements are 
therefore inaccurate and probably underestimate the actual concentration. 
 
Table S2. Isolated RNA (after DNase digestion) 
Sample RNA* Concentration Volume RNA amount Ratio 260/280 
Ratio 
260/230 
DD01 22.0 µL RNA 01 2085.2 ng/µL 100 µL 209 µg 2.14 2.33 
DD02 22.0 µL RNA 01 1684.5 ng/µL 100 µL 168 µg 2.14 2.42 
DD03 4.5 µL RNA 01 21.5 µL RNA 02 2039.5 ng/µL 100 µL 204 µg 2.14 2.40 
DD04 27.0 µL RNA 02 1685.1 ng/µL 100 µL 169 µg 2.14 2.40 
DD05 22.0 µL RNA 03 1753.6 ng/µL 100 µL 175 µg 2.13 2.37 
DD06 22.0 µL RNA 03 1667.2 ng/µL 100 µL 167 µg 2.12 2.35 
DD07 22.0 µL RNA 04 1639.4 ng/µL 100 µL 164 µg 2.12 2..36 
DD08 22.0 µL RNA 04 1523.9 ng/µL 100 µL 152 µg 2.11 2.37 
DD09 22.0 µL RNA 05 1776.7 ng/µL 100 µL 178 µg 2.12. 2.34 
DD10 22.0 µL RNA 05 1035.0 ng/µL 100 µL 104 µg 2.09 2.31 
DD11 48,5 µL RNA 06 1376.5 ng/µL 100 µL 138 µg 2.11 2.32 
DD12 22.0 µL RNA 07 1763.9 ng/µL 100 µL 176 µg 2.13 2.38 
DD13 22.0 µL RNA 07 1969.1 ng/µL 100 µL 197 µg 2.13 2.37 
DD14 
4.5 µL RNA 03  
4.5 µL RNA 04   
4.5 µL RNA 05   
4.5 µL RNA 07 
3643.9 ng/µL 100 µL 364 µg 2.06 2.26 
DD15 21.0 µL RNA 08 1509.4 ng/µL 100 µL 151 µg 2.11 2.37 
DD16 21.0 µL RNA 08 1658.1 ng/µL 100 µL 166 µg 2.12 2.38 
DD17 24.0 µL RNA 09 2000.6 ng/µL 100 µL 200 µg 2.13 2.33 
DD18 24.5 µL RNA 09 1928.9 ng/µL 100 µL 193 µg 2.13 2.36 
DD19 24.0 µL RNA 10 1516.5 ng/µL 100 µL 152 µg 2.13 2.34 
DD20 24.5 µL RNA 10 1558.0 ng/µL 100 µL 156 µg 2.12 2.37 
DD21 21.0 µL RNA 11 2020.9 ng/µL 100 µL 202 µg 2.11 2.39 
G. Appendix 
 76 
DD22 21.0 µL RNA 11 1891.3 ng/µL 100 µL 189 µg 2.11 2.41 
DD23 21.0 µL RNA 12 2188.7 ng/µL 100 µL 219 µg 2.13 2.39 
DD24 21.0 µL RNA 12 1266.5 ng/µL 100 µL 127 µg 2.08 2.37 
DD25 
6.5 µL RNA 08  
6.5 µL RNA 11 
6.5 µL RNA 12 
2470.1 ng/µL 100 µL 247 µg 2.12 2.39 
*The RNA samples (Table S1) were distributed to in order not to exceed the maximum 
amount of RNA per digestion reaction. 
 
 
Table S3. MICROBEnrich results of 10 performances 
Name of    
RNA sample total RNA enriched RNA 
LK2 55 µg 5.3 µg (9.6 %) 
LK2 100 µg 18.7 µg (18.7%) 
LK2 100 µg 29.1 µg (29.1%) 
K2 50 µg 10.8 µg (21.6%) 
DD03 100 µg 26.1 µg (26.1%) 
DD18 50 µg 3.7 µg (7.4%) 
DD14 50 µg 3.8 µg (7.6%) 
RNA-TRI 50 µg 7.7 µg (15.4%) 
RNA-easy 50 µg 6.2 µg (12.4%) 
 
 
Table S4. Initial labelings with preliminary nucleotide  mix 
RNA template Template 
amount Fluorophore 
cDNA      
(µg) 
Cy3/5 
(pmol) FOI 
LK2 (total RNA) 20 µg Cy5 2.8 514 60 
LK2 (total RNA) 20 µg Cy5 2.5 470 62 
LK2 (total RNA) 20 µg Cy5 1.2 194 55 
LK2 (total RNA) 20 µg Cy5 1.5 249 57 
LK2 (total RNA) 20 µg Cy5 1.7 290 55 
LK2 (total RNA) 20 µg Cy5 1.6 288 58 
LK2 (total RNA) 20 µg Cy3 2.8 516 60 
LK2 (total RNA) 20 µg Cy3 2.7 544 66 
LK2 (total RNA) 20 µg Cy3 3.2 692 70 
LK2 (total RNA) 20 µg Cy3 3.0 668 73 
LK2 (total RNA) 20 µg Cy3 2.7 588 70 
K1 (total RNA) 20 µg Cy3 1.8 480 87 
K1 (total RNA) 20 µg Cy3 1.7 412 79 
K1 (total RNA) 20 µg Cy3 1.6 396 78 
K1 (total RNA) 20 µg Cy3 1.9 452 77 
K1 (total RNA) 20 µg Cy3 1.6 372 73 
LK2 (enriched RNA) 5 µg Cy3 0.9 180 67 
LK2 (enriched RNA) 5 µg Cy5 2.2 130 46 
LK2 (enriched RNA) 5 µg Cy5 1.9 115 41 
LK2 (enriched RNA) 10 µg Cy5 3.3 142 25 
LK2 (enriched RNA) 5 µg Cy3 2.0 352 58 
LK2 (enriched RNA) 5 µg Cy3 1.7 312 61 
LK2 (enriched RNA) 5 µg Cy3 1.7 320 62 
LK2 (enriched RNA) 5 µg Cy3 1.8 344 62 
LK2 (enriched RNA) 5 µg Cy3 1.4 272 61 
*RNA templates for the initial labeling were isolated by Susanne Haider. 
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Table S5. Second labeling series with preliminary nucleotide mix 
RNA template Template 
amount Fluorophore 
cDNA      
(µg) 
Cy3/5 
(pmol) FOI 
DD01 (total RNA) 10 µg Cy5 1.6 310 62 
DD01 (total RNA) 10 µg Cy5 1.5 262 55 
DD01 (total RNA) 10 µg Cy5 1.6 254 52 
DD01 (total RNA) 10 µg Cy5 1.5 235 51 
DD01 (total RNA) 10 µg Cy5 1.4 278 64 
DD01 (total RNA) 10 µg Cy5 1.5 314 67 
DD01 (total RNA) 10 µg Cy3 3.3 812 80 
DD01 (total RNA) 10 µg Cy3 2.7 644 78 
DD02 (total RNA) 10 µg Cy5 1.6 310 63 
DD02 (total RNA) 10 µg Cy5 1.2 228 62 
DD02 (total RNA) 10 µg Cy5 1.4 257 58 
DD02 (total RNA) 10 µg Cy5 1.8 290 54 
DD02 (total RNA) 10 µg Cy5 1.3 242 62 
DD02 (total RNA) 10 µg Cy5 1.2 206 54 
DD02 (total RNA) 10 µg Cy5 1.3 240 62 
DD02 (total RNA) 10 µg Cy5 1.5 288 63 
DD02 (total RNA) 10 µg Cy3 1.6 340 70 
DD02 (total RNA) 10 µg Cy3 1.3 268 65 
DD02 (total RNA) 10 µg Cy3 1.3 224 57 
DD02 (total RNA) 10 µg Cy3 1.3 260 63 
DD02 (total RNA) 10 µg Cy3 1.3 280 72 
DD02 (total RNA) 10 µg Cy3 1.2 268 71 
DD03 (enriched RNA) 5 µg Cy5 1.8 286 53 
DD03 (enriched RNA) 5 µg Cy5 2.2 461 69 
DD03 (enriched RNA) 16 µg Cy5 2.7 593 70 
 
Table S6. Optimization of the nucleotide mix 
RNA 
template 
Template 
amount Fluorophore 
Ratio          
dTTP:aa-dUTP 
cDNA      
(µg) 
Cy3/5 
(pmol) FOI 
DD04 10 µg Cy3 1:2 2.0 208 34 
DD04 10 µg Cy3 1:2 2.0 208 34 
DD04 10 µg Cy3 1:2 2.1 472 72 
DD04 10 µg Cy3 1:2 2.0 460 76 
DD04 10 µg Cy3 1:2 2.2 456 67 
DD04 10 µg Cy3 1:2 2.1 424 67 
DD04 7 µg Cy3 1:2 1.3 228 56 
DD04 7 µg Cy3 1:2 1.3 252 64 
DD04 7 µg Cy3 1:2 1.3 228 58 
DD04 5 µg Cy3 1:2 1.1 220 66 
DD04 5 µg Cy3 1:2 1.1 216 62 
DD04 5 µg Cy3 1:2 1.2 212 60 
DD04 5 µg Cy3 1:2 1.2 204 55 
DD04 10 µg Cy3 1:2 2.0 420 67 
DD04 10 µg Cy3 1:2 2.3 428 61 
DD04 10 µg Cy3 1:2 1.2 224 58 
DD04 10 µg Cy3 1:2 1.3 224 57 
DD05 10 µg Cy3 1:1 1.2 208 34 
DD05 10 µg Cy3 1:1 1.3 208 33 
DD05 10 µg Cy3 2:1 0.8 84 32 
DD05 10 µg Cy3 2:1 1.1 84 26 
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Table S7: Further optimization of nucleotide mix for Cy3 
RNA 
template 
Template 
amount Fluorophore 
Ratio          
dTTP:aa-dUTP 
cDNA      
(µg) 
Cy3/5 
(pmol) FOI 
DD05 10 µg Cy3 1:1 1.3 164 40 
DD05 10 µg Cy3 1:1 1.2 160 43 
DD05 10 µg Cy3 1:1 1.8 256 45 
DD05 10 µg Cy3 1:1 2.2 284 43 
DD05 10 µg Cy3 1:1 1.6 224 44 
DD05 10 µg Cy3 1:1 1.5 196 42 
DD05 10 µg Cy3 1:1 1.1 144 42 
DD05 10 µg Cy3 1:1 1.2 168 45 
DD05 10 µg Cy3 1:1 1.4 168 39 
DD05 10 µg Cy3 1:1 1.4 152 34 
DD06 10 µg Cy3 1:1 2.6 372 47 
DD06 10 µg Cy3 1:1 2.5 376 50 
DD06 10 µg Cy3 1:1 2.1 332 52 
DD06 10 µg Cy3 1:1 2.6 404 50 
DD09 10 µg Cy3 1:1 2.3 296 42 
DD09 10 µg Cy3 1:1 1.9 272 46 
DD09 10 µg Cy3 1:1 1.8 260 46 
DD09 10 µg Cy3 1:1 1.7 220 41 
DD09 10 µg Cy3 1:1 1.0 164 51 
DD09 10 µg Cy3 1:1 0.9 132 47 
DD09 10 µg Cy3 1:1 0.9 164 57 
DD09 10 µg Cy3 1:1 0.9 144 50 
DD17 10 µg Cy3 2:1 0.7 56 26 
DD17 10 µg Cy3 2:1 0.7 40 18 
DD17 10 µg Cy3 2:1 0.6 52 29 
DD17 10 µg Cy3 2:1 0.6 52 29 
DD23 10 µg Cy3 4:3 1.4 192 45 
DD23 10 µg Cy3 4:3 1.0 132 43 
DD23 10 µg Cy3 4:3 1.2 144 40 
DD23 10 µg Cy3 4:3 1.5 188 41 
DD23 10 µg Cy3 4:3 1.5 192 42 
DD23 10 µg Cy3 4:3 1.0 140 45 
DD23 20 µg Cy3 3:2 7.2 608 27 
DD21 20 µg Cy3 3:2 7.5 656 28 
DD21 20 µg Cy3 4:3 6.2 704 37 
 
Table S8. Aminoallyl labeling in Cy5 
RNA 
template 
Template 
amount Fluorophore 
cDNA      
(µg) 
Cy3/5 
(pmol) FOI 
DD06 10 µg Cy5 1.3 134 34 
DD06 10 µg Cy5 1.0 113 35 
DD06 10 µg Cy5 1.7 180 35 
DD06 10 µg Cy5 2.0 209 35 
DD06 10 µg Cy5 2.1 199 31 
DD06 10 µg Cy5 1.8 192 34 
DD06 10 µg Cy5 1.8 197 36 
DD06 10 µg Cy5 1.9 216 36 
DD07 10 µg Cy5 0.8 67 27 
DD07 10 µg Cy5 0.8 72 28 
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DD07 10 µg Cy5 0.7 50 22 
DD07 10 µg Cy5 0.8 74 29 
DD07 10 µg Cy5 0.8 89 34 
DD07 10 µg Cy5 0.9 77 29 
DD07 10 µg Cy5 0.8 70 27 
DD07 10 µg Cy5 0.7 60 27 
DD07 10 µg Cy5 0.4 46 33 
DD07 10 µg Cy5 0.5 48 31 
DD07 10 µg Cy5 0.7 60 28 
DD07 10 µg Cy5 0.5 48 31 
DD09 10 µg Cy5 1.8 194 35 
DD09 10 µg Cy5 1.8 204 37 
DD09 10 µg Cy5 2.1 254 40 
DD09 10 µg Cy5 1.9 199 35 
DD09 10 µg Cy5 1.8 192 35 
DD09 10 µg Cy5 1.8 185 34 
DD13 10 µg Cy5 1.6 185 37 
DD13 10 µg Cy5 1.7 194 38 
DD13 10 µg Cy5 1.7 192 37 
DD13 10 µg Cy5 1.6 190 38 
DD13 10 µg Cy5 1.6 163 34 
DD13 10 µg Cy5 1.8 194 35 
DD13 10 µg Cy5 1.5 163 36 
DD13 10 µg Cy5 1.5 158 34 
DD17 10 µg Cy5 2.1 250 39 
DD17 10 µg Cy5 2.3 286 41 
DD17 10 µg Cy5 2.0 228 37 
DD17 10 µg Cy5 2.4 290 39 
DD17 10 µg Cy5 2.1 252 40 
DD17 10 µg Cy5 2.2 245 37 
DD17 10 µg Cy5 1.9 230 39 
DD17 10 µg Cy5 2.3 276 39 
DD17 10 µg Cy5 3.4 341 33 
DD17 10 µg Cy5 3.0 307 33 
DD23 10 µg Cy5 1.8 173 31 
DD23 10 µg Cy5 1.6 154 31 
DD23 10 µg Cy5 1.4 137 31 
DD23 10 µg Cy5 1.6 151 31 
DD23 10 µg Cy5 1.8 175 32 
DD23 10 µg Cy5 1.4 139 31 
DD23 10 µg Cy5 1.6 156 33 
DD23 10 µg Cy5 1.3 115 29 
DD23 10 µg Cy5 1.5 132 29 
DD23 10 µg Cy5 1.5 137 30 
DD23 10 µg Cy5 1.3 139 34 
DD23 10 µg Cy5 1.4 122 29 
DD21 80 µg Cy5 18.5 1517 27 
DD18 80 µg Cy5 19.9 1978 32 
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Table S9. Direct labelings of amplified cDNA and gDNA controls 
Template mRNA enrichment 
Reverse 
transcription 
cDNA 
amplification 
Restriction 
digestion Purification 
Fluoro-
phore 
labelled 
DNA (µg)* 
Cy3 
(pmol)* FOI* 
DD18       Cy3 10.4 207 6 
DD18       Cy3 9.9 190 6 
DD18        Cy3 7.8 147 6 
DD18        Cy3 4.8 60 4 
DD18       Cy3 13.6 283 7 
DD18       Cy3 12.7 173 4 
DD18        Cy3 2.0 10 2 
RNA-TRI      Cy3 8.1 100 4 
RNA-TRI      Cy3 7.8 83 3 
RNA-easy      Cy3 4.8 70 5 
RNA-easy      Cy3 6.6 77 4 
gDNA        Cy3 10.3 143 5 
gDNA        Cy3 11.9 223 6 
* The labeling parameters were calculated analogous to the indirect labeling (C.9.4.) but with 
a different extinction coefficient (e = 50 µg cm mL-1) for double stranded DNA since 
amplification generates DNA that is mostly double stranded. 
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H. Abbreviations  
 
16S rRNA  small ribosomal RNA subunit of prokaryotes 
18S rRNA  small ribosomal RNA subunit of eukaryotes 
28S rRNA  large ribosomal RNA subunit of prokaryotes 
%   percent 
°C   degree celsius 
A   adenine 
A.   Acanthamoeba 
aa-cDNA  aminoallyl cDNA 
aa-dUTP  aminoallyl dUTP 
ATCC   American Type Culture Collection 
BLAST  basic local alignment search tool 
bp   base pairs 
BSA   bovine serum albumine 
c   centi (10-2) 
C   cytosine 
C.   Chlamydia; Chlamydophila 
cDNA   complementary DNA 
CLSM   confocal laser scanning microscope 
CTAB   cetyl trimethylammonium bromide 
dATP   deoxyadenosine triphosphate 
dCTP   deoxycytosine triphosphate 
ddH2O   double distilled water 
DAPI   4’-6-di-amidino-2-phenylindol 
DEPC   diethylpyrocarbonate 
dGTP   deoxyguanine triphosphate 
DIC   differential interference contrast 
DMSO  dimethyl sulfoxide 
dNTP   deoxynucleotide triphosphate 
dTTP   deoxythymidine triphosphat 
dUTP   deoxyuracil triphosphate 
DNA   deoxyribonucleic acid 
DNase   deoxyribonuclease 
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DTT   dithiothreitol 
E.   Escherichia 
EB   elementary body 
EDTA   ethylenediaminetetraacetic acid 
et al.   et alteri (latine, “and others”) 
FISH   fluorescence in situ hybridization 
FOI   frequency of incorporation 
g   gram(s); gravitational constant 
gDNA   genomic DNA 
h   hour(s) 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
L   litre(s) 
m   meter(s); milli (10-3) 
M   molar 
min   minute(s) 
mol   mole 
mRNA  messenger RNA 
n   nano (10-9) 
NNA   non-nutrient agar 
nt   nucleotide(s) 
ORF   open reading frame 
P.   Protochlamydia 
PAS   Page’s amoebic saline 
PCR   polymerase chain reaction 
p   pico (10-12) 
PYG   peptone-yeast-glucose medium 
PYNFH  peptone-yeast-nucleic acid-folic acid-hemin medium 
RB   reticulate body 
RNA   ribonucleic acid 
RNase   ribonuclease 
rpm   revolutions per minute 
rRNA   ribosomal RNA 
RT   room temperature; reverse transcriptase 
S   Siemens 
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SDS   sodium dodecyl sulfate 
sec   seconds 
SNR   signal-to-noise ratio 
sp.   species 
SPG   sucrose-phosphate-glutamate buffer 
SSC   sodium carbonate-sodium citrate buffer 
T   thymine 
Ta   annealing temperature 
TAE   Tris-acetate-EDTA buffer 
Taq   thermostable DNA polymerase from Thermus aquaticus 
TBE   Tris-borate-EDTA buffer 
TE   Tris-EDTA buffer 
Tris   tris(hydroxymethyl)aminomethane 
tRNA   transfer RNA 
TSY   trypticase soy broth with yeast extract 
U   unit 
UV   ultraviolet 
vol   volume 
x    arithmetic mean 
ε   molar extinction coefficient 
µ   micro (10-6) 
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